STOCK PURCHASE AGREEMENT by and between THORATEC CORPORATION and ITC NEXUS HOLDING COMPANY, INC. Dated as of November 4, 2010
Exhibit 2.1
EXECUTION COPY
by and between
THORATEC CORPORATION
and
ITC NEXUS HOLDING COMPANY, INC.
Dated as of November 4, 2010
EXECUTION COPY
TABLE OF CONTENTS
Page | ||||
ARTICLE I. DEFINITIONS |
1 | |||
1.1. Defined Terms |
1 | |||
1.2. Other Defined Terms |
9 | |||
ARTICLE II. PURCHASE AND SALE OF SHARES |
10 | |||
2.1. Agreement to Sell and Purchase |
10 | |||
2.2. Purchase Price |
10 | |||
ARTICLE III. CLOSING |
10 | |||
3.1. Closing |
10 | |||
3.2. Payment of Purchase Price |
10 | |||
3.3. Deliveries at Closing |
10 | |||
ARTICLE IV. REPRESENTATIONS AND WARRANTIES OF SELLER |
12 | |||
4.1. Title to Shares; Encumbrance on Assets |
12 | |||
4.2. Seller Organization |
12 | |||
4.3. Seller Power and Authority |
12 | |||
4.4. Non-Contravention |
12 | |||
4.5. Capitalization |
13 | |||
4.6. Government Authorizations |
13 | |||
4.7. Company Organization |
13 | |||
4.8. No Material Adverse Effect |
14 | |||
4.9. Financial Statements |
14 | |||
4.10. Absence of Undisclosed Liabilities |
14 | |||
4.11. Real Property |
14 | |||
4.12. Labor and Employment Matters |
16 | |||
4.13. Employee Benefit Plans |
16 | |||
4.14. Litigation |
18 | |||
4.15. Environmental, Health and Safety Matters |
18 | |||
4.16. Permits; Compliance with Law |
19 | |||
4.17. Tax Matters |
21 | |||
4.18. Contracts |
22 | |||
4.19. Intellectual Property |
23 | |||
4.20. No Brokers |
25 | |||
4.21. Absence of Changes |
25 | |||
4.22. Unlawful Payments |
27 | |||
4.23. Affiliate Transactions |
27 | |||
4.24. Significant Customers and Suppliers |
27 | |||
4.25. Insurance |
28 |
i
Page | ||||
4.26. Warranties; Products |
28 | |||
4.27. Sufficiency of Assets |
29 | |||
4.28. Intercompany Arrangements |
29 | |||
4.29. No Implied Representations |
29 | |||
ARTICLE V. REPRESENTATIONS AND WARRANTIES OF BUYER |
29 | |||
5.1. Organization |
29 | |||
5.2. Authorization |
30 | |||
5.3. Non-Contravention |
30 | |||
5.4. Government Authorizations |
30 | |||
5.5. Litigation |
30 | |||
5.6. No Brokers |
30 | |||
5.7. Financing |
30 | |||
5.8. No Implied Representation |
30 | |||
ARTICLE VI. COVENANTS OF SELLER AND BUYER |
31 | |||
6.1. Further Assurances |
31 | |||
6.2. Material Contracts |
31 | |||
6.3. ISRA |
31 | |||
6.4. Employee Matters |
32 | |||
6.5. Confidentiality |
34 | |||
6.6. Public Announcements |
35 | |||
6.7. [Intentionally Omitted.] |
35 | |||
6.8. Non-Competition; Non-Solicitation |
35 | |||
6.9. [Intentionally Omitted] |
37 | |||
6.10. Insurance |
37 | |||
6.11. Checks Payable; Payroll; Cash |
37 | |||
6.12. Cooperation; Financial Reporting |
38 | |||
6.13. Title Insurance and Surveys |
38 | |||
ARTICLE VII. [INTENTIONALLY OMITTED] |
39 | |||
ARTICLE VIII. [INTENTIONALLY OMITTED] |
39 | |||
ARTICLE IX. SURVIVAL AND INDEMNIFICATION |
39 | |||
9.1. Survival |
39 | |||
9.2. Indemnification |
40 | |||
9.3. Limitations on Indemnification |
42 | |||
ARTICLE X. TAX MATTERS |
45 | |||
10.1. Preparation of Tax Returns |
45 | |||
10.2. Transfer Taxes |
46 |
ii
Page | ||||
10.3. Cooperation; Taxes |
46 | |||
10.4. Tax Treatment of Indemnification Payments |
46 | |||
10.5. Tax Claims |
46 | |||
ARTICLE XI. MISCELLANEOUS |
46 | |||
11.1. [Intentionally Omitted] |
46 | |||
11.2. Assignment; Successors and Assigns; No Third Party Rights |
47 | |||
11.3. Specific Performance |
47 | |||
11.4. Notices |
48 | |||
11.5. Governing Law |
49 | |||
11.6. Entire Agreement; Amendments and Waivers |
49 | |||
11.7. Counterparts |
49 | |||
11.8. Expenses |
49 | |||
11.9. Severability |
50 | |||
11.10. Titles; Gender; Certain Interpretive Matters |
50 | |||
11.11. Seller Disclosure Schedule; Construction of Certain Provisions |
50 | |||
11.12. Service of Process, Consent to Jurisdiction; WAIVER OF JURY TRIAL |
51 | |||
11.13. Independence of Agreements, Covenants, Representations and Warranties |
51 |
iii
THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of November 4, 2010, is by
and between Thoratec Corporation, a California corporation (“Seller”), and ITC Nexus
Holding Company, Inc., a Delaware corporation (“Buyer”). Seller and Buyer are each a
“Party” and collectively, the “Parties”.
RECITALS
WHEREAS, Seller is the sole record and beneficial owner of one hundred percent (100%) of the
outstanding shares of common stock, no par value per share (the “Shares”), of International
Technidyne Corporation (the “Company”); and
WHEREAS, Seller wishes to sell to Buyer, and Buyer wishes to purchase from Seller, all of the
Shares, upon the terms and subject to the conditions of this Agreement.
AGREEMENT
NOW THEREFORE, in consideration of the foregoing and the respective representations,
warranties, covenants and agreements of the Parties contained herein, and for other good and
valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties,
intending to be legally bound, hereby agree as follows:
ARTICLE I.
DEFINITIONS
1.1. Defined Terms. As used herein, the terms below shall have the following meanings.
Any of such terms, unless the context otherwise requires, may be used in the singular or plural,
depending upon the reference.
“Action” means any action, Claim, suit, litigation, arbitration, audit or
proceeding.
“Affiliate” has the meaning set forth in Rule 12b-2 of the regulations promulgated
under the Exchange Act.
“Agreement” means this Agreement (including the Seller Disclosure Schedule), as the
same may be amended, modified or supplemented from time to time in accordance with its terms.
“Alternate Site Products” means the (a) ProTime® Microcoagulation System (including
cuvettes and other consumables related thereto), (b) InRythm/MyRythm products (including cuvettes
and other consumables related thereto), and (c) any current systems, products or platforms or
future systems, products or platforms of the Company (x) that are marketed primarily for the use of
prothrombin testing of blood samples by individual patients in their homes and by physicians and
medical professionals in medical offices and clinics as currently planned (but not including the
use of such testing in hospitals) and (y) that are substantially derived (including as to
technology and Intellectual Property) from the products set forth in
clauses (a) or (b) above. All such systems described in clauses (a) and (b) above and all such
current systems described in clause (c) above are set forth in Section 1.1(a) of the Seller
Disclosure Schedule. For the avoidance of doubt, the Alternate Site Products do not include any
products that are sold to pharmaceutical customers of the Company.
“Assets” means all tangible, intangible and other assets, claims, rights and
properties of any kind, whether accrued, contingent or otherwise, used, held for use or owned by
the Company.
“Business Day” means any day other than Saturday, Sunday or any day that is a legal
holiday or a day in which banking institutions in New York are authorized by Law or other
Governmental Order to close.
“Buyer Indemnified Parties” means Buyer and its Affiliates (including, for the
avoidance of doubt, the Company) and their respective equityholders, Representatives, successors
and permitted assigns (which, for the avoidance of doubt, shall not include Seller).
“Cash” means cash, cash equivalents and short-term marketable securities of any
Person.
“Claim” means any claim, demand, cause of action, chose in action, right of recovery
or right of set-off of whatever kind or description against any Person.
“Code” means the Internal Revenue Code of 1986, as amended.
“Company Financial Statements” means the unaudited balance sheets of the Company as of
December 29, 2007, January 3, 2009, January 2, 2010 and September 30, 2010 and the related
statements of income for the periods then ended.
“Company Real Property” means, collectively, the Owned Real Property and the Leased
Real Property.
“Confidentiality Agreement” means that certain Confidential Disclosure Agreement,
dated as of August 10, 2010 by and between Nexus Dx, Inc. and Seller.
“Consents” means consents, orders, approvals, exemptions, waivers,
authorizations, filings, registrations and notifications.
“Contract” means any oral or written contract, agreement, indenture, note, bond, loan,
instrument, lease, conditional sale contract, mortgage, license, franchise, commitment, undertaking
or other binding arrangement.
“Controlling” means the possession, directly or indirectly, of the power to
direct the management and policies of a Person whether through the ownership of voting
securities, contract or otherwise.
“Customer Offerings” means the products that the Company (i) currently sells or
licenses to third parties or (ii) has sold or licensed to third parties since January 1, 2007.
2
“Encumbrance” means any pledge, charge, easement, security interest, mortgage, right
of first refusal, option, encumbrance, lien (statutory or otherwise), preference or restriction on
transfer.
“Enforcement Action” means the issuance or grant of Injunctive Relief or Product
Relief, or the execution of a Consent Decree.
“Environmental Laws” means all Laws regulating or imposing Liabilities or standards of
conduct concerning pollution or the protection of the environment, including the use, manufacture,
transport, disposal or release of Hazardous Materials, Petroleum or worker health and safety (to
the extent related to exposure to Hazardous Materials), together with any amendment or
reauthorization thereto or thereof, as now or at any time hereafter in effect, including the
Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended.
“Equity Interests” means (a) the shares of capital stock of a corporation, (b) the
general or limited partnership interests of any partnership, (c) the membership or other ownership
interest of any limited liability company, (d) the equity securities or other ownership interests
of any kind of any other legal entity, or (e) any option, warrant or other right to convert into or
otherwise receive any of the foregoing, in any such case, whether owned or held beneficially, of
record or legally.
“ERISA” means the Employee Retirement Income Security Act of 1974, as amended.
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
“FDA Event” means the occurrence of any of the following events on or prior to March
31, 2011 (the “FDA Outside Date”): (a) the issuance by a court or other Governmental
Authority of competent jurisdiction of an injunction or similar relief (“Injunctive
Relief”) against the Company that affects the manufacture or sale of any products by or on
behalf of the Company or the business or operations of the Company; (b) the FDA or any other
Governmental Authority shall (i) seize any products manufactured or sold by or on behalf of the
Company, or (ii) place any prohibition or limitation on the Company’s ability to import, export,
ship or sell any products manufactured or sold by or on behalf of the Company (the matters referred
to in clauses (i) and (ii), being referred to herein as “Product Relief”); or (c) the FDA
or any other Governmental Authority shall threaten to take any of the actions specified in the
immediately preceding clause (a) or (b), and as result thereof or in connection therewith, the
Company and the FDA or such other Governmental Authority, as the case may be, shall enter into a
consent decree or similar agreement that affects the manufacture or sale of any products by or on
behalf of the Company or the business or operations of the Company (a “Consent Decree”);
provided, however, that an FDA Event shall only be deemed to have occurred pursuant
to the immediately preceding clauses (a), (b) or (c) if the issuance of the Injunctive Relief, the
granting of the Product Relief or the execution of the Consent Decree, as applicable, arises out of
or results from the inspection and audit of the Company that was commenced by the FDA on October
13, 2010 (the “Current FDA Audit”), it being understood and agreed that, for all purposes
of this Agreement, the Current FDA Audit shall include any and all inspections or audits of the
3
Company by the FDA that are undertaken on or prior to the FDA Outside Date as follow-up to, or to
confirm compliance by the Company with the findings, requests and recommendations of the FDA issued
in connection with, the inspection and audit of the Company that was commenced by the FDA on
October 13, 2010; provided further, however, that if on or before the FDA Outside
Date, the FDA or any other Governmental Authority shall commence any action or proceeding seeking,
or shall threaten in writing to seek, any Enforcement Action, then the FDA Outside Date shall be
extended until the earlier of (1) in the event any such action or proceeding has been commenced or
any written threat seeking an Enforcement Action has been received, the date such action or
proceeding (or written threat seeking an Enforcement Action) has been finally resolved, or (2)
September 30, 2011.
“FDA Section” means Section 4.16, other than clause (a) of such Section.
“Fundamental Representations and Warranties” means (a) those representations and
warranties contained in Section 4.1 (Title to Shares; Encumbrance on Assets), the first sentence of
Section 4.2 (Seller Organization), Section 4.3 (Seller Power and Authority), Section 4.4 (Seller
Non-Contravention), Section 4.5 (Capitalization), the first sentence of Section 4.7 (Company
Organization), Section 4.20 (No Brokers), Section 4.23 (Affiliate Transactions), and Section 4.28
(Intercompany Arrangements), and (b) those representations and warranties contained in the first
sentence of Section 5.1 (Organization), Section 5.2 (Authorization) and Section 5.6 (No Brokers).
“GAAP” means United States generally accepted accounting principles.
“Governmental Authority” means any court, government (federal, state, local, foreign
or multinational) or other regulatory, self-regulatory, administrative, governmental or
quasi-governmental agency or authority, whether foreign or domestic.
“Governmental Authorization” means any permit, consent, license, certificate,
franchise, permission, variance, clearance, registration, qualification, authorization or approval
issued, granted, given or otherwise made available by or under the authority of any Governmental
Authority or pursuant to any Law, including any Company Permit.
“Governmental Order” means any judgment, decision, consent decree, injunction, ruling,
writ or order of or entered by any Governmental Authority that is binding on any Person or its
property under applicable Law.
“Hazardous Materials” means any material, substance or waste defined, listed or
regulated as “hazardous” or “toxic” (or words of similar meaning or intent) under any applicable
Environmental Law, including, without limitation, materials exhibiting the characteristics of
ignitability, corrosivity, reactivity or toxicity characteristic leaching procedure, as such terms
are defined in connection with hazardous materials or hazardous wastes or hazardous or toxic
substances in any applicable Environmental Law, any other material, substance or waste for which
Liability or standards of conduct may be imposed under any Environmental Law.
“Indebtedness” shall mean at a particular time, without duplication, (a) any
obligations under or for any indebtedness for borrowed money (including, without limitation, all
principal,
4
premiums, fees, expenses, indemnities and breakage costs paid to satisfy such indebtedness),
whether current or funded, or secured or unsecured; (b) any indebtedness evidenced by any note,
bond, debenture or other debt security; (c) obligations as lessee under any leases which are
required to be capitalized in accordance with GAAP, contingently or otherwise, as obligor or
guarantor; (d) obligations for deferred purchase price of property or services (excluding
obligations to creditors for goods and services incurred in the original course of business); (e)
amounts owed with respect to letters of credit; (f) any change of control or other amounts due to
any Person to the extent incurred and payable as a result of the consummation of the transactions
contemplated by this Agreement; and (g) accrued interest or penalties on any of the foregoing.
“Intellectual Property” means the following subsisting throughout the world: (a)
patents, patent applications, utility models, design registrations and certificates of invention
and other governmental grants for the protection of inventions or industrial designs (including all
related continuations, continuations-in-part, divisionals, reissues and reexaminations); (b)
registered trademarks and service marks, logos, Internet domain names, corporate names, domain
names and doing business designations and all registrations and applications for registration of
the foregoing, common law trademarks and service marks and trade dress, and all goodwill in the
foregoing; (c) copyrights, designs, data and database rights and registrations and applications for
registration thereof, including moral rights of authors; (d) mask works and registrations and
applications for registration thereof and any other rights in semiconductor topologies under the
Laws of any jurisdiction; (e) inventions, invention disclosures, statutory invention registrations,
trade secrets and confidential business information, know-how, manufacturing and product processes
and techniques, research and development information, financial, marketing and business data,
pricing and cost information, business and marketing plans and customer and supplier lists and
information, whether patentable or non-patentable, whether copyrightable or non-copyrightable and
whether or not reduced to practice; and (f) other proprietary rights relating to any of the
foregoing (including remedies against infringement thereof and rights of protection of interest
therein under the Laws of all jurisdictions).
“ISRA” means the New Jersey Industrial Site Recovery Act, N.J.S.A. 13:1K-6 et seq.
and the regulations promulgated thereunder.
“Knowledge” shall mean, in the case of (a) Seller, the actual knowledge (provided that
the following individuals shall conduct reasonable inquiry in connection with any applicable
matters) of Xxxx Xxxxxxx, Xxxxx Xxxxx, Xxxxx Xxxxxx, Xxxxx Xxxxx, Xxx Xxxxx, Xxxx Xxxxxxx, Xxxxx
Xxxxxx, Xxxx Xxxxxxxxxx, Xxxx Xxxxxxx, Xxxxx Xxxxxx and Xxxxxx Xxxxxx, and (b) Buyer, the actual
knowledge of any executive officer or Buyer.
“Laws” means any laws (including common law), statutes, ordinances, regulations,
rules, executive orders, and acts of any Governmental Authority.
“Leased Real Property” means the properties set forth in Section 1.1(b) of the
Seller Disclosure Schedule.
“Liabilities” means any direct or indirect liability, Indebtedness, obligation,
commitment, expense, claim, deficiency, guaranty or endorsement of or by any Person of any type,
whether
5
absolute or contingent, matured or unmatured, liquidated or unliquidated, accrued or unaccrued,
asserted or unasserted, known or unknown, whenever arising, including all costs and expenses
relating thereto, and including, without limitation, those liabilities, indebtedness and
obligations arising under any Law, Claim, Action, threatened Action, Governmental Order or any
award of any arbitrator of any kind, and those arising under any Contract. Unless the context
otherwise requires or as otherwise expressly specified, reference in this Agreement to
“Liabilities” shall mean Liabilities of the Company.
“Losses” means any and all costs, losses, Liabilities, obligations, damages,
deficiencies and other out-of-pocket expenses, including, without limitation, interest, penalties,
reasonable attorneys’ fees and reasonable costs of investigation and defense and all amounts paid
in settlement of Actions relating to the foregoing, whether or not arising out of any Third Party
Claims. Notwithstanding the foregoing, solely with respect to Losses arising from any
indemnification obligations of Seller pursuant to Section 9.2(a)(v), “Losses” shall not include any
costs related to the hiring or compensation of any additional personnel (whether Company employees
or third-party contractors) that arises directly out of any Enforcement Action, including any such
costs attributable to the monitoring (including any third-party audit(s)) of the Company’s business
or operations required by the FDA as a direct result of the Enforcement Action.
“Material Adverse Effect” means any event, change, development or effect (whether or
not constituting a breach of a representation, warranty, covenant or agreement set forth herein)
that (a) with respect to the Company, individually or in the aggregate, has had or could reasonably
be expected to have a material adverse effect on the business, operations, Assets, Liabilities, or
financial condition of the Company, excluding for all purposes of this Agreement other than Section
4.8 hereof, any such effect to the extent resulting from (i) changes in general economic, industry
or market conditions, in each case that do not have, and would not reasonably be expected to have,
a disproportionate effect on the Company relative to other Persons in the industry in which the
Company primarily operates, (ii) changes in applicable Laws, (iii) any adverse change or effect
that is caused by the announcement of the transactions contemplated by this Agreement, (iv) the
failure, by itself, of the Company to meet or achieve the results set forth in any internal
projection (it being understood that the facts and circumstances giving rise to such failure may be
taken into account to determine whether or not there has been a Material Adverse Effect), (b) with
respect to Buyer, has a material and adverse effect on the ability of Buyer to consummate the
transactions contemplated hereby or materially impairs the ability of Buyer to perform its
obligations under this Agreement, or (c) with respect to Seller, has a material and adverse effect
on the ability of Seller to consummate the transactions contemplated hereby or materially impairs
the ability of Seller to perform its obligations under this Agreement.
“Ordinary Course of Business” or “Ordinary Course” or any similar phrase means
the ordinary course of the business conducted by the Company, consistent with past practice.
“Organizational Documents” means, with respect to any Person, such Person’s charter,
by-laws, certificate of incorporation, limited liability company agreement, partnership agreement
or other similar organizational document(s).
6
“Owned Real Property” means the properties set forth in Section 1.1(c) of the
Seller Disclosure Schedule.
“Permitted Encumbrances” means (a) Encumbrances imposed by Law arising in the Ordinary
Course of Business, such as carriers’, warehousemen’s, mechanics’, materialmen’s, landlords’,
laborers’, suppliers’ and vendors’ liens, and securing obligations which are not yet due or which
are being contested in good faith, (b) Encumbrances for Taxes not due and payable or being
contested in good faith and for which adequate reserves have been established in accordance with
GAAP, (c) planning restrictions, easements, licenses, rights of way, declarations, reservations,
provisions, covenants, conditions, waivers, irregularities or Encumbrances (and, with respect to
leasehold interests, Encumbrances and other obligations incurred, created, assumed or permitted to
exist and arising by, through or under a landlord or owner of the leased property, with or without
consent of the lessee) which do not impair in any material respect the use (in the manner currently
used) or value of the parcel of property to which they relate, (d) zoning, entitlement,
conservation restriction and other land use and environmental regulations imposed by Governmental
Authorities which do not impair in any material respect the use (in the manner currently used) or
value of the parcel of property to which they relate, and (e) any extensions, renewals and
replacements of an identical or lesser scope of any of the foregoing.
“Person” means an individual, a partnership, a corporation, a limited liability
company, a trust, an unincorporated organization, a Governmental Authority or any other entity.
“Petroleum” means petroleum, including crude oil (or any fraction or blend of
fractions thereof), gasoline, natural gas diesel fuel, motor oil, waste or used oil, heating oil,
kerosene.
“Pre-Closing Taxable Period” means any Tax period ending on or before the Closing
Date.
“Pre-Closing Taxes” means Taxes of the Company or for which the Company becomes liable
with respect to a Tax period ending on or before the Closing Date and, in the case of a Straddle
Period, the Taxes allocable pursuant to the following sentence to the portion of such Straddle
Period ending on the Closing Date, in each case excluding any Taxes incurred solely by reason of
any transaction outside the Ordinary Course effected after the Closing and any Taxes attributable
to any election applicable to a Pre-Closing Taxable Period or Straddle Period filed by Buyer
without Seller’s prior written consent. The portion of any Tax that is allocable to the portion of
the Straddle Period ending on the Closing Date will be: (i) in the case of real property, personal
property and similar ad valorem Taxes, deemed to be the amount of such Taxes for the entire
Straddle Period multiplied by a fraction, the numerator of which is the number of calendar days of
such Straddle Period up to and including the Closing Date, and the denominator of which is the
number of calendar days in the entire Straddle Period, and (ii) in the case of all other Taxes,
determined as though the Straddle Period terminated at the close of business on the Closing Date.
Notwithstanding the foregoing, Pre-Closing Taxes shall not include payroll Taxes for a weekly or
biweekly payroll period of the Company in which the Closing occurs (other than the regular weekly
payroll period referred to in Section 6.11(b)).
7
“Product Warranties” means all product warranties and guaranties given by the Company
since January 1, 2007.
“Representative” means, with respect to any Person, any officer, director, principal,
attorney, agent, employee, consultant, advisor or other authorized representative of such Person
(including legal counsel, accountants, and financial advisors).
“Securities Act” means the Securities Act of 1933, as amended.
“Seller Disclosure Schedule” means the disclosure schedule delivered by Seller to
Buyer on the date hereof.
“Seller Indemnified Parties” means Seller and its Affiliates (other than the Company)
and their respective equityholders, Representatives, successors and permitted assigns.
“Specified Representations and Warranties” means those representations and warranties
contained in Section 4.9(a) (Financial Statements), Section 4.13 (Employee Benefit Plans), Section
4.15 (Environmental, Health and Safety Matters), Section 4.17 (Tax Matters), Section 4.19
(Intellectual Property), Section 4.21(l) and Section 4.21(m) (Absence of Changes), Section 4.27
(Sufficiency of Assets) and the FDA Section.
“Straddle Period” means any Tax period beginning on or before the Closing Date and
ending after the Closing Date.
“Subsidiary” shall mean, with respect to any of the Parties, any corporation, limited
liability company, partnership, association or other business entity of which (a) if a corporation,
a majority of the total voting power of shares of capital stock entitled (without regard to the
occurrence of any contingency) to vote in the election of directors, managers or trustees thereof
is at the time owned or controlled, directly or indirectly, by any such Party, or (b) if a limited
liability company, partnership, association or other business entity, a majority of the partnership
or other similar ownership interest thereof is at the time owned or controlled, directly or
indirectly, by any such Party.
“Surviving Representations and Warranties” means the Fundamental Representations and
Warranties and the Specified Representations and Warranties.
“Tax” means any federal, state, local or foreign tax, charge, duty, fee, levy or other
assessment, including income, branch profits, gross receipts, license, payroll, employment, excise,
escheat, severance, stamp, occupation, premium, windfall profits, environmental, customs duties,
capital stock, franchise, profits, withholding, social security (or similar), unemployment,
disability, real property, personal property, sales, use, transfer, registration, value added, ad
valorem, alternative or add-on minimum, estimated or other tax, or like charges of any kind
whatsoever, imposed by any Governmental Authority, and including any interest, penalty or addition
thereto, and including any amount owed as a result of Treasury Regulations Section 1.1502-6 or any
similar provision of Law.
8
“Tax Return” means any return, declaration, report, Claim for refund or information
return or statement relating to Taxes, including any schedule or attachment thereto, and including
any amendment thereof, required to be filed with any Governmental Authority.
1.2. Other Defined Terms. The following terms shall have the meanings defined for such
terms in the Sections set forth below:
Term | Section | |
Benefit Plans
|
4.13(a) | |
Buyer Plan
|
6.4(c) | |
Claim Notice
|
9.2(c) | |
Closing
|
3.1 | |
Closing Date
|
3.1 | |
Company Benefit Plans
|
4.13(a) | |
Company Intellectual Property
|
4.19(b) | |
Company Permits
|
4.16(a) | |
Company Systems
|
4.19(g) | |
Competing Business
|
6.8(a) | |
Confidential Information
|
6.5 | |
FDA
|
4.16(b) | |
FD&C Act
|
4.16(b) | |
Health and Welfare Benefit Plans
|
6.4(a) | |
Indemnified Claim
|
9.2(e) | |
Injunctive Relief
|
1.1 | |
Insurance Policies
|
4.25 | |
Insured Loss
|
9.3(b) | |
Material Contracts
|
4.18(a) | |
Non-Competition Period
|
6.8(a) | |
Notice Period
|
9.2(c) | |
Product Relief
|
1.1 | |
Purchase Price
|
2.2 | |
Restricted Party
|
6.8(a) | |
Seller Group Returns
|
10.1(a) | |
Separate Company Returns
|
10.1(b) | |
Significant Customer
|
4.24(a) | |
Significant Supplier
|
4.24(a) | |
Surviving Covenants
|
9.1(b) | |
Tax Claims
|
10.5 | |
Territory
|
6.8(a) | |
Third Party Claim
|
9.2(c) | |
Thoratec Financial Statements
|
4.9 | |
Threshold Amount
|
9.3(a) | |
Transaction Expenses
|
11.8 | |
Transition Services Agreement
|
3.3(a)(viii) | |
Transition Services Expiration Date
|
6.4(a) |
9
ARTICLE II.
PURCHASE AND SALE OF SHARES
2.1. Agreement to Sell and Purchase. On the date hereof and upon the terms contained
in this Agreement, Seller shall sell, convey, transfer, assign and deliver all of the Shares free
and clear of all Encumbrances to Buyer, and Buyer shall purchase and accept all of the Shares from
Seller in exchange for the Purchase Price (as defined below).
2.2. Purchase Price. The Purchase Price for the Shares shall be an amount equal
to $55,000,000 (the “Purchase Price”), payable in accordance with Section 3.2.
ARTICLE III.
CLOSING
3.1. Closing. The closing of the purchase and sale of the Shares (the
“Closing”) shall be held at 10:00 a.m. New York time at the offices of Xxxxxx & Xxxxxxx
LLP, at 000 Xxxxx Xxxxxx, Xxx Xxxx, XX 00000, on the date hereof (the “Closing Date”),
unless the Parties hereto otherwise agree in writing.
3.2. Payment of Purchase Price. Upon the terms contained in this Agreement, in
consideration of the aforesaid sale, conveyance, transfer, assignment and delivery of the Shares,
Buyer will pay Seller at the Closing the Purchase Price, by wire transfer of immediately available
funds to an account designated in writing by Seller.
3.3. Deliveries at Closing.
(a) To effect the transactions contemplated hereby, Seller shall, at the Closing,
deliver to Buyer, or cause to be delivered to Buyer (unless previously delivered):
(i) a stock certificate, duly endorsed by Seller for transfer to Buyer,
representing the Shares and any other documents necessary to transfer to Buyer good and
marketable title to the Shares free and clear of all Encumbrances (other than restrictions
under applicable securities Laws);
(ii) the letters of resignation of the members of the board of directors of the
Company;
(iii) an affidavit of Seller, dated as of the Closing Date and substantially in the
form set forth in Treasury Regulations
Section 1.1445-2(b), certifying Seller’s non-foreign status;
Section 1.1445-2(b), certifying Seller’s non-foreign status;
(iv) a release and waiver from Seller and its Subsidiaries (other than the
Company), with respect to pre-Closing matters involving the Company;
10
(v) a certificate executed by the Secretary of the Company (and, as applicable, in
the case of clauses (C) and (D) below, Seller) certifying that attached thereto are (A) a
true, complete and correct copy of the certificate of incorporation of the Company, as in
effect on the Closing Date, certified by an appropriate authority of the State of Delaware,
(B) a true, complete and correct copy of the by-laws of the Company, as in effect on the
Closing Date, (C) true, complete and correct copies of resolutions of the Company’s Board of
Directors and the sole stockholder, respectively, authorizing the execution, delivery and
performance of this Agreement and the transactions contemplated hereby, which resolutions
have not been modified, rescinded or revoked, and (D) specimen signatures of the officers of
the Company and Seller authorized to sign this Agreement and the other documents delivered
by Seller pursuant to this Agreement;
(vi) with respect to Seller, a certificate issued by an appropriate authority of
the State of California, certifying as of a date no more than ten (10) days prior to the
Closing Date that Seller is in good standing under the Laws of the State of California;
(vii) with respect to the Company, a certificate issued by the Secretary of State of
the State of Delaware and each other jurisdiction in which the Company is qualified to do
business, certifying as of a date no more than ten (10) days prior to the Closing Date that
the Company is in good standing under the Laws of such jurisdictions;
(viii) a duly executed counterpart to that certain Transition Services Agreement, in
the form attached hereto as Exhibit A (the “Transition Services Agreement”);
(ix) written evidence of the termination of the Contracts referred to in the
second sentence of Section 4.28, which shall be reasonably satisfactory in form and
substance to Buyer; and
(x) all such other documents, certificates and instruments as Buyer may
reasonably request in order to give effect to the transactions contemplated hereby.
(b) To effect the transactions contemplated hereby, Buyer shall, at the Closing,
deliver to Seller, or cause to be delivered to Seller (unless previously delivered):
(i) an amount equal to the Purchase Price, payable in accordance with Section 3.2
hereof; and
(ii) a duly executed counterpart to the Transition Services Agreement.
(c) Each such document contemplated by this Section 3.3 shall be in form and
substance, and shall be executed and delivered in a manner, reasonably satisfactory to the
Parties.
11
ARTICLE IV.
REPRESENTATIONS AND WARRANTIES OF SELLER
Seller hereby represents and warrants to Buyer as follows:
4.1. Title to Shares; Encumbrance on Assets. Seller owns all of the Shares
beneficially and of record, free and clear of any Encumbrance and, upon delivery of and payment for
such Shares at the Closing as herein provided, Seller will convey to Buyer good and valid title
thereto, free and clear of any Encumbrance. Except as set forth on Section 4.1 of the Seller
Disclosure Schedule, the Company owns all of its Assets free and clear of any Encumbrance (other
than Permitted Encumbrances).
4.2. Seller Organization. Seller is a corporation duly organized, validly existing and
in good standing under the laws of the State of California, with the requisite corporate power and
authority to conduct its business as it is presently being conducted. Seller is duly qualified or
licensed to do business in each jurisdiction in which the property owned, leased or operated by
Seller or the nature of the business conducted by Seller makes such qualification necessary, except
in any such jurisdictions where the failure to be duly so qualified or licensed would not have a
Material Adverse Effect on Seller.
4.3. Seller Power and Authority. Seller has all requisite corporate power and
authority and has taken all corporate action necessary, to execute and deliver this Agreement and
the other agreements contemplated hereby, to consummate the transactions contemplated hereby and
thereby, and to perform its obligations hereunder and thereunder. This Agreement and the other
agreements contemplated hereby have been duly executed and delivered by Seller and, assuming the
due authorization, execution and delivery of this Agreement and such other agreements by Buyer, are
legal, valid and binding obligations of Seller, enforceable against Seller in accordance with their
respective terms, except as may be limited by the effects of bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium and other similar Laws relating to or affecting creditors’
rights generally and general equitable principles (whether considered in a proceeding in equity or
at law).
4.4. Non-Contravention. Except as set forth on Section 4.4 of the Seller Disclosure
Schedule, neither the execution and delivery of this Agreement or the other agreements contemplated
hereby by Seller, nor the consummation of the transactions contemplated hereby or thereby will (a)
conflict with or result in a breach or violation of any provision of the Organizational Documents
of Seller or the Company or, to the Knowledge of Seller, any resolution of the board of directors
of Seller or the Company; (b) violate or result in a default or breach of (or an event that with
notice or lapse of time or both would become a default or breach) or give rise to any right of
termination, modification, Consent or acceleration under, or result in the loss of any material
right or the imposition of any Liability under, any material Contract of Seller or a Material
Contract of the Company; (c) violate any Law or any Governmental Order applicable to Seller or the
Company; (d) result in the creation of any Encumbrance on the Shares or any material Asset; or (e)
result in a default under or a breach or
12
violation of, or adversely affects the rights and benefits afforded to the Company by, any
Company Permit.
4.5. Capitalization.
(a) The authorized equity capitalization of the Company consists of one hundred (100) shares
of common stock, of which one hundred (100) shares are issued and outstanding. The Shares are duly
authorized, validly issued, fully paid and non-assessable and were not issued in violation of, and
are not currently subject to, any preemptive right, right of first refusal or other similar rights.
Other than the Shares, the Company has no other shares of capital stock or other Equity Interests
issued or outstanding.
(b) Seller has good and valid title to the Shares, with the full legal right, authority and
power to sell, transfer and convey the Shares to Buyer in accordance with the terms of this
Agreement.
(c) All of the Shares were offered, issued, sold and delivered by the Company in compliance
with all applicable Laws governing the issuance of securities. There are no outstanding or
authorized equity appreciation, phantom equity or similar rights with respect to the Company.
Neither Seller nor the Company is party to any Contract with a third party with respect to the
voting, sale, transfer or purchase of the Shares and no Person has any outstanding or authorized
option, warrant, right, call, commitment, subscription right, conversion right, exchange right,
preemptive right or other securities or agreements (written or oral, firm and conditional) or any
right or privilege capable of becoming an option, warrant, right, call, commitment, subscription
right, conversion right, exchange right, preemptive right or other security or agreement pursuant
to which (i) Seller or the Company is or may become obligated to issue, sell, transfer or otherwise
dispose of, redeem or acquire any of the Shares, or any interest in the share capital of the
Company or (ii) Seller or the Company has granted, or may be obligated to grant, to any Person
(other than a registered holder of Shares and in respect of such Shares only), a right to
participate in the profits of the Company.
(d) The Company has no Subsidiaries. The Company does not own any Equity Interest, or
any interest convertible or exchangeable into an Equity Interest, in any Person.
4.6. Government Authorizations. No Consent of, with or to any Governmental Authority
is required to be obtained or made by the Company, Seller or Seller’s Subsidiaries in connection
with the execution and delivery of this Agreement, the other agreements being entered into
concurrently herewith or the consummation of the transactions contemplated hereby or thereby.
4.7. Company Organization. The Company is a corporation duly organized, validly
existing and in good standing under the laws of the State of Delaware, with the requisite corporate
power and authority to conduct its business as it is presently being conducted. The Company is duly
qualified or licensed to do business in each jurisdiction in which the property owned, leased or
operated by the Company or the nature of the business conducted by the Company makes such
qualification necessary (which jurisdictions are listed on Section 4.7 of the Seller Disclosure
Schedule), except in any such jurisdictions where the failure to be duly so qualified or licensed
would not have a Material Adverse Effect on the Company.
13
4.8. No Material Adverse Effect. Since January 2, 2010 and through the date hereof,
there has not been a Material Adverse Effect on the Company.
4.9. Financial Statements.
(a) Subject to the limitations with respect thereto as set forth in the succeeding provisions
of this Section 4.9(a), true and complete copies of the Company Financial Statements are set forth
on Section 4.9(a) of the Seller Disclosure Schedule. The Company Financial Statements (i) have been
prepared from the books and records of the Company on a consistent basis through the periods
covered thereby, (ii) have been prepared in accordance with GAAP applied on a consistent basis
through the periods covered thereby (except (A) as set forth in the explanatory footnotes thereto,
(B) with respect to the treatment of stock-based compensation expense therein and (C) with respect
to the treatment of federal and state income Taxes) and (iii) fairly present, in all material
respects, the financial position and results of operations of the Company as of their respective
dates. Each of the audited balance sheets of Thoratec Corporation as of December 29, 2007, January
3, 2009 and January 2, 2010 and the related statements of income for the fiscal years then ended
(collectively, the “Thoratec Financial Statements”) contain the relevant Company Financial
Statements for the time periods applicable thereto. The Thoratec Financial Statements have been
prepared in accordance with GAAP applied on a consistent basis through the periods covered thereby
and fairly present, in all material respects, the financial position and results of operations of
Seller as of their respective dates. Except as set forth on Section 4.9(a) of the Seller Disclosure
Schedule, the Company has no outstanding Indebtedness and no Indebtedness shall be incurred by the
Company in connection with the execution and delivery of this Agreement or the consummation of the
transactions contemplated hereby.
(b) Except as set forth on Section 4.9(b) of the Seller Disclosure Schedule, Seller and the
Company have established and maintained a system of internal control over financial reporting (as
defined in Rule 13a-15 under the Exchange Act) that provides, in all material respects, reasonable
assurance regarding the reliability of Seller’s and the Company’s financial reporting and the
preparation of Seller’s and the Company’s financial statements for external purposes in accordance
with GAAP.
4.10. Absence of Undisclosed Liabilities. The Company has no Liabilities, except those
that (i) are properly reflected on the face of the Company Financial Statements, (ii) have been
incurred in the Ordinary Course of Business since the date of the latest balance sheet included in
the Company Financial Statements, (iii) are set forth on Section 4.10 of the Seller Disclosure
Schedule or (iv) are not, individually or in the aggregate, expected to result in Liabilities to
the Company and its business greater than $37,500.
4.11. Real Property.
(a) Section 4.11(a) of the Seller Disclosure Schedule sets forth a true, complete and
correct listing of each parcel of Owned Real Property (including street address, legal description
(if known), owner and the Company’s use thereof). With respect to each parcel of Owned Real
Property:
14
(i) except as set forth on Section 4.11(a)(i) of the Seller Disclosure Schedule,
the Company has good, valid, insurable, marketable and fee simple title to such Owned Real
Property, free and clear of all Encumbrances (except for Permitted Encumbrances) and Buyer
will receive such title and/or interest in the Owned Real Property at the Closing free and
clear of all Encumbrances (other than Permitted Encumbrances); and
(ii) neither Seller nor the Company has leased or otherwise granted to any Person
the right to use or occupy such Owned Real Property or any portion thereof.
(b) Section 4.11(b) of the Seller Disclosure Schedule sets forth a true, complete and correct
listing of all Leased Real Property (including street address, legal description (if known),
lessor, rent and the Company’s use thereof), and a true, complete and correct list of all lease
Contracts for such Leased Real Property. Seller has made available to Buyer true and complete
copies of each such lease Contract, as amended through the date hereof. With respect to each such
lease Contract:
(i) the Company has a valid leasehold interest to the leasehold estate in the
Leased Real Property granted to the Company pursuant to each such lease Contract;
(ii) each such lease Contract is, and will continue to be, legal, valid, binding,
enforceable and in full force and effect against the parties thereto in accordance with
its terms following the consummation of the transactions contemplated hereby;
(iii) no event has occurred or circumstance exists which, with the delivery of
notice, the passage of time or both, would constitute a material breach or default under
such lease Contract; and
(iv) neither Seller nor the Company has assigned, transferred, conveyed, mortgaged,
deeded in trust or encumbered any interest in any Leased Real Property held pursuant to such
lease Contract.
(c) Except as set forth on Section 4.11(c) of the Seller Disclosure Schedule, the Company Real
Property and all present uses and operations of the Company Real Property comply in all material
respects with easements and disposition agreements affecting the Company Real Property and there
are no pending or, to the Knowledge of Seller, threatened condemnation, fire, health, safety,
building, zoning or other land use regulatory proceedings, lawsuits or administrative actions
relating to any portion of the Company Real Property or the current use, occupancy or value
thereof, nor has the Company or Seller received written notice of any pending or threatened special
assessment proceedings affecting any portion of the Company Real Property, in each case except to
the extent that such actions or notice would result in a Material Adverse Effect on the Company.
(d) To the Knowledge of Seller, no fact or condition exists which could result in the
termination or material reduction of the current access from the Company Real Property to existing
roads or to water, sewer or other utility services presently serving such Company Real Property.
15
4.12. Labor and Employment Matters.
(a) The Company is not a party to a collective bargaining agreement and none of the Company’s
employees are represented by a union or other labor organization, association or bargaining agent,
and to the Knowledge of Seller, no such organizing efforts are now being conducted or pending with
respect to Company employees.
(b) There are no charges of employment discrimination, sexual harassment or unfair labor
practices or strikes, slowdowns, stoppages of work or any other concerted interference with normal
operations pending, or to the Knowledge of Seller, threatened against or involving the Company.
Since January 1, 2005, the Company is and has been in compliance in all material respects with all
applicable Laws respecting labor, employment, fair employment practices, terms and conditions of
employment, worker’s compensation, plant closings, immigration, wages and hours, employment
discrimination and occupational safety and health requirements.
(c) During the past two (2) years, the Company has not implemented any layoffs that implicate
the Worker Adjustment and Retraining Notification Act of 1988, as amended, or any similar state or
local Law.
(d) Except as set forth on Section 4.12(d) of the Seller Disclosure Schedule, there is no
unfair labor practice charge or complaint or any representation petitions or other similar
petitions or requests for representation pending, or, to the Knowledge of Seller, proposed or
threatened against or involving the Company before the National Labor Relations Board or any other
Governmental Authority and there is no litigation, grievance, arbitration proceeding, governmental
investigation, citation or Action of any kind pending, or, to the Knowledge of Seller, proposed or
threatened against the Company relating to labor, employment, fair employment practices, terms and
conditions of employment, worker’s compensation, plant closings, immigration, wages and hours,
employment discrimination or occupational safety and health requirements.
(e) Seller has provided to Buyer a complete and accurate list of all employees employed by the
Company as of October 20, 2010, by identification number, and, to the extent such information may
be shared consistent with applicable Law, their titles, beginning service dates, current wages
(salaries or hourly rates of pay), vacation entitlements and guaranteed bonuses. To the extent such
information may be shared consistent with applicable Law, Seller has provided to Buyer whether such
employees are on inactive status, including lay-off, short-term disability leave, long-term
disability leave, pregnancy and parental leave or other extended absence, or are receiving benefits
pursuant to workers’ compensation legislation, and specifies the last date of active employment,
the reason for the absence and the expected date of return of each such employee. All of the
employees of the Company perform functions for and provide services exclusively to the Company.
4.13. Employee Benefit Plans.
(a) Set forth on Section 4.13(a) of the Seller Disclosure Schedule are all Benefit Plans.
“Benefit Plans” shall mean (i) “employee benefit plans” (within the meaning of Section 3(3)
of ERISA, including, without limitation, multiemployer plans within the meaning of Section
16
3(37) of ERISA), and (ii) all other retirement, deferred compensation, profit sharing, stock
purchase, stock option and other equity-based, health and disability insurance, employment,
severance, change in control, “golden parachute,” retention, consulting, bonus, incentive,
collective bargaining, fringe benefit and all other employee benefit plans, agreements, programs,
policies or other arrangements, whether or not subject to ERISA, in each case, (i) that cover or
are otherwise applicable to any of the employees or former employees of the Company, (or any
dependents or beneficiaries thereof) or (ii) with respect to which the Company has any present or
future or actual or contingent Liability (Benefit Plans sponsored or maintained solely by the
Company are referred to herein as the “Company Benefit Plans” and Section 4.13(a) of the
Seller Disclosure Schedule separately identifies all Company Benefit Plans). Except as set forth on
Section 4.13(a) of the Seller Disclosure Schedule, with respect to each Benefit Plan, Seller has
provided, or made available, to Buyer a current, accurate and complete copy (or, an accurate
description) thereof and any summary plan description, and with respect to each Company Benefit
Plan, to the extent applicable: (i) any related trust agreement or other funding instrument, (ii)
the most recent determination or opinion letter, and (iii) for the two most recent years, the Form
5500 and attached schedules, audited financial statements and actuarial valuation reports prepared
or required to be prepared with respect thereto.
(b) Except as set forth on Section 4.13(b) of the Seller Disclosure Schedule, (i) each Benefit
Plan which is intended to be qualified within the meaning of Section 401(a) of the Code is so
qualified and has received a favorable determination letter as to its qualification, and the
Company is not aware of any facts or circumstances that could reasonably be expected to cause the
loss of such qualification, (ii) no event has occurred that has subjected, and, to the Knowledge of
Seller, no condition exists that would subject, the Company, either directly or by reason of its
affiliation with any member of its “Controlled Group” (defined as any organization which is a
member of a controlled group of organizations within the meaning of Sections 414(b), (c), (m) or
(o) of the Code), to any material tax, fine, lien, penalty or other Liability imposed by ERISA, the
Code or other applicable Laws, (iii) no nonexempt “prohibited transaction” (as such term is defined
in Section 406 of ERISA and Section 4975 of the Code) has occurred with respect to any Benefit
Plan, except as would not, individually or in the aggregate, reasonably be expected to result in
material Liability of the Company, (iv) none of the Company or any member of the Controlled Group
has at any time within the past six (6) years maintained, sponsored or contributed to, or has or
had any Liability or obligation in respect of, any employee benefit plan that is subject to Title
IV of ERISA, including any “multiemployer plan” (as defined in Section 4001(a)(3) of ERISA), (v)
the Company has not incurred any current or projected Liability in respect of post-employment or
post-retirement health, medical or life insurance benefits for Company employees or former
employees, except as required under COBRA, (vi) each Benefit Plan has been established and operated
in compliance in all material respects with all applicable Laws and (vii) there are no pending or,
to the Knowledge of Seller, threatened Claims, disputes or investigations involving or related to
any Benefit Plan that would reasonably be expected to result in a material Liability.
(c) Except as set forth on Section 4.13(c) of the Seller Disclosure Schedule, neither the
execution of this Agreement nor the consummation of the transactions contemplated hereby (whether
alone or in connection with any other event(s)) could (i) result in severance pay or any increase
in severance pay upon any termination of employment of any Company employee, (ii)
17
accelerate the time of payment or vesting or result in any payment or funding (through a grantor
trust or otherwise) of compensation or benefits under, or increase the amount payable or result in
any other material obligation pursuant to, any of the Benefit Plans with respect to which the
Company or Buyer would be responsible, (iii) limit or restrict the right of the Company to merge,
amend or terminate any of the Benefit Plans, or (iv) result in payments under any of the Benefit
Plans which would not be deductible under Section 280G of the Code.
(d) All amounts which are required to be paid or contributed by the Company in respect of
any Benefit Plan (A) for any period ending prior to December 31, 2009, shall have been fully and
timely paid or contributed; and (B) for any period thereafter, shall have been either fully and
timely paid or contributed or properly accrued as a reserve.
4.14. Litigation. Except as set forth on Section 4.14 of the Seller Disclosure
Schedule, there is no, and, during the three (3) years prior to the date hereof, has not been any,
material Action pending or, to the Knowledge of Seller, threatened, against or involving (a) the
Company or (b) to the Knowledge of Seller, any current or former officer, director or employee of
the Company which would reasonably be expected to result in a Liability to the Company. Except as
set forth on Section 4.14 of the Seller Disclosure Schedule, the Company is not subject to any
material Governmental Order and no notice of any Action, governmental investigation or inquiry
involving the Company, whether pending or, to the Knowledge of Seller, threatened, has been
received by the Company or Seller during the last three (3) years.
4.15. Environmental, Health and Safety Matters.
(a) The Company is and, during the five (5) years prior to the date hereof, has been, in
compliance in all material respects with all applicable Environmental Laws, which compliance has
included obtaining and complying at all times and in all material respects with all material
permits required under applicable Environmental Laws.
(b) Except as set forth on Section 4.15(b) of the Seller Disclosure Schedule, the Company has
not, during the five (5) years prior to the date hereof, received any written notice, Claim or
report from any Governmental Authority or third party regarding either (i) any material violation
of Environmental Laws by the Company; (ii) any allegation of any actual or potential material
responsibility or Liability of the Company under Environmental Laws; or (iii) relating to any
disposal, release or threatened release of, or exposure to, any Hazardous Materials or Petroleum
for which the Company has potential Liability except, in the case of either (i), (ii) or (iii)
above, with regard to matters that have been fully and finally resolved prior to the date hereof
without future obligation.
(c) The Company has not used, stored, treated, transported, manufactured, refined, handled,
produced, emitted, released, disposed of, arranged for or permitted the disposal of, or exposed any
Person to, any Hazardous Materials or Petroleum, including on, under, at or from the Company Real
Property, except in compliance in all material respects with applicable Environmental Law and as
would not give rise to any material Liability or material investigatory, corrective or remedial
obligation pursuant to any Environmental Law.
18
(d) The Company does not own or operate any property or facility and has not previously owned
or operated any property or facility which is or has been contaminated by any Hazardous Material or
Petroleum so as to give rise to any material Liabilities of the Company or material investigatory,
corrective or remedial obligations of the Company under Environmental Laws. There is no asbestos
contained in or forming part of any building, structure or asset at the Company Real Property
except for such material that is being maintained in compliance with applicable Environmental Laws
and would not give rise to any material Liabilities. Except as set forth on Section 4.15(d) of the
Seller Disclosure Schedule, there is not now nor has there ever been any asbestos or mercury
contained in or forming part of any products currently or previously manufactured, distributed or
sold by the Company or any of its predecessors (or any other Person for whose conduct any of them
are or may be responsible).
(e) The Company is not subject to any Action or any Governmental Order pursuant to
Environmental Law or relating to any Hazardous Material or Petroleum.
(f) The Company has not, expressly or by operation of Law, assumed, undertaken, or provided an
indemnity with respect to any material Liability or any material investigatory, corrective or
remedial obligation, of any other Person relating to Environmental Laws, including any Release of
Hazardous Materials or Petroleum.
(g) Seller has made available to Buyer true, complete and correct copies of all material
environmental site assessments, audits, reports and all other documents materially bearing on
environmental, health or safety Liability related to the past or current operations, properties or
facilities of the Company (including, without limitation, the environmental condition of the
Company Real Property), in each case which are in the possession of Seller or the Company or under
the reasonable control of Seller or the Company.
(h) Notwithstanding anything to the contrary contained in this Agreement, the
representations and warranties in this Section 4.15 are the sole and exclusive representations and
warranties of Seller concerning environmental matters, including any matters arising under
Environmental Laws.
4.16. Permits; Compliance with Law.
(a) Except as set forth on Section 4.16(a) of the Seller Disclosure Schedule, (i) the
Company is, and since January 1, 2005, has been, in possession and operating in compliance in all
material respects with all franchises, grants, authorizations, licenses, permits, easements,
variances, exceptions, Consents, certificates, approvals and orders of any Governmental Authority
material to its business as it is now being conducted (the “Company Permits”), (ii) the
Company Permits are valid and subsisting and, as of the date of this Agreement, no modification,
termination, suspension or cancellation of any of the Company Permits is pending or, to the
Knowledge of Seller, threatened, (iii) the Company is and has conducted its business in compliance
in all material respects with the requirements, standards, criteria and conditions set forth in the
Company Permits and (iv) the Company or Seller has delivered to Buyer true, complete and correct
copies of all material Company Permits.
19
(b) Except as set forth on Section 4.16(b) of the Seller Disclosure Schedule, (i) the Company
is conducting and has conducted its business and operations since January 1, 2005 in compliance in
all material respects with all applicable Laws, (ii) the Company is conducting and has conducted
its business and operations in compliance in all material respects with (A) the reporting
requirements of Section 519 of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 321 et
seq. (including the applicable rules and regulations thereunder and the regulations
promulgated pursuant thereto, the “FD&C Act”), including compliance with the written
procedures, record-keeping and the U.S. Food and Drug Administration (“FDA”) reporting
requirements for Medical Device Reporting set forth in 21 C.F.R. Part 803, (B) the Quality System
Regulation set forth in 21 C.F.R. Part 820, (C) the rules and regulations of the FDA and comparable
foreign, state and local rules and regulations regarding clinical investigations, good clinical
practices, and good laboratory practices, and (D) all other rules and regulations of the FDA and
comparable foreign, state and local rules and regulations and (iii) the Company has not received
any written notice or communication from any Governmental Authority alleging noncompliance with any
applicable Law.
(c) Except as set forth on Section 4.16(c) of the Seller Disclosure Schedule, the Company (i)
has not received any Form 483s, shutdown or import or export prohibition, warning letter or
untitled letters from the FDA or similar correspondence or notices or Actions from any other
Governmental Authority asserting noncompliance with any applicable Law, Company Permit or other
requests or requirements of a Governmental Authority during the last five (5) years and (ii) has
not received any written communication from any Governmental Authority or been notified in writing
during the last five (5) years that any Company Permit is withdrawn or modified or that such an
action is under consideration except, in each case, as would not be material to the Company, and
the Company has not received any requests or requirements to make changes to any product or
proposed product that, if not complied with, would be material to the Company.
(d) The clinical trials conducted by or on behalf of or sponsored by the Company or in which
the Company test its products were and, if still pending, are being conducted in all material
respects (i) to the Knowledge of Seller in accordance with the relevant clinical trial protocol and
generally accepted good clinical medical and scientific research practices and procedures and (ii)
in accordance with applicable Law, and all applicable rules and regulations of the FDA and
comparable foreign, state and local rules and regulations. No investigational device exemption
filed by or on behalf of the Company with the FDA has been terminated, held or suspended by the
FDA.
(e) Seller has provided to Buyer true, to the extent within the possession or in the control
of Seller or the Company, complete and correct copies of the following regarding or involving the
Company or any third party manufacturer or supplier of the Company: (A) all material warning
letters, untitled letters, notices of adverse findings and similar correspondence; (B) all material
submissions, reports or other documents (including any telephone or meeting notes) related to
recalls or corrections and removals reports, including all correspondence to and from the FDA and
the Company related thereto; and (C) all material reports and other written communication
(including any telephone or meeting notes) that pertain to assessing compliance of the Company’s or
the Company’s suppliers’ operations with respect to the Company’s
20
products or any third party manufacturer’s production of the Company’s products with respect to the
FD&C Act or other applicable Laws and regulations, including all inspection reports and lists of
observations relating to inspections for compliance with the FD&C Act.
4.17. Tax Matters.
(a) Except as set forth on Section 4.17(a) of the Seller Disclosure Schedule, (i) Seller and
the Company have timely filed with the appropriate Governmental Authority all material Tax Returns
required to have been filed by or with respect to the Company, and each such Tax Return is correct
and complete in all material respects, (ii) all Taxes of the Company (and Seller, with respect to
the Company), whether or not shown as due and payable on a Tax Return, have been timely paid and
(iii) neither the Company nor any consolidated, combined, affiliated or similar group of which the
Company is a member is currently the beneficiary of any extension of time within which to file any
material Tax Return.
(b) Except as set forth on Section 4.17(b) of the Seller Disclosure Schedule, (i) neither the
Company nor any consolidated, combined, affiliated or similar group of which the Company is a
member has waived any statute of limitations in respect of Taxes or agreed to any extension of time
with respect to a Tax assessment or deficiency, (ii) no deficiencies for Taxes with respect to the
Company or any consolidated, combined, affiliated or similar group of which the Company is a member
have been claimed, proposed or assessed which deficiency remains unresolved and (iii) no audit or
other proceeding relating to Taxes of the Company or any consolidated, combined, affiliated or
similar group of which the Company is a member is pending or has been threatened in writing.
(c) Except as set forth on Section 4.17(c) of the Seller Disclosure Schedule, there are no
Encumbrances for Taxes on or against any material Assets of the Company, other than Encumbrances
for current Taxes not due and payable or being contested in good faith.
(d) Since January 2, 2010, the Company has not incurred any Liability for Taxes outside the
Ordinary Course of Business.
(e) Since February 14, 2001, the Company has not been a member of any affiliated group filing
a consolidated Tax Return for U.S. federal income tax purposes other than the affiliated group the
common parent of which is Seller.
(f) The Company is not a party to any Tax sharing agreement or Tax allocation agreement.
(g) The Company has not been a party to any transaction intended to qualify under Section 355
of the Code at any time in the last two years.
(h) Except as set forth on Section 4.17(h) of the Seller Disclosure Schedule, the Company
has withheld and paid all material Taxes required to have been withheld and paid in connection with
amounts paid to any employee, independent contractor, creditor or stockholder of the Company.
21
(i) Neither the Company nor any consolidated, combined, affiliated or similar group of
which the Company is a member has been a party to a transaction that is a “listed transaction,” as
such term is defined in Treasury Regulations Section 1.6011-4.
4.18. Contracts.
(a) “Material Contracts” shall include any of the following Contracts to which the
Company is a party or otherwise bound, each of which is listed on Section 4.18(a) of the Seller
Disclosure Schedule:
(i) any Contract with any customer of the Company representing revenues of at
least $1,000,000 for the Company for 2008, 2009 or the nine month period ended September 30,
2010;
(ii) any Contract with any Significant Supplier (other than any purchase orders
entered into in the Ordinary Course of Business that are subject to customary and standard
terms and conditions);
(iii) any Contract with any officer, director or employee of Seller or the Company
or any Affiliate of any such Person, or any other Affiliate of the Company or Seller, on the
one hand, and the Company, on the other hand (other than (A) offer letters for employment on
an at-will basis, (B) customary confidentiality, assignment of inventions and/or
noncompetition or other similar arrangements and (C) any Contract with any stockholder of
Seller that, to the Knowledge of Seller, owns in excess of five percent (5%) of the
outstanding common stock of Seller and is not an director, officer or employee of Seller or
the Company);
(iv) any outstanding loan agreements, guarantee agreements, letters of credit,
mortgages, promissory notes or other documents relating to Indebtedness of the Company,
including intercompany loans and Indebtedness between the Company and Seller or any
Subsidiary of Seller;
(v) any Contract to which the Company is a party which prohibits the Company from
entering into any line of business or supplying products to any customer or potential
customer in any part of the world (other than any Contract with a customer or supplier
entered into in the Ordinary Course of Business);
(vi) any Contract to buy or sell a material portion of the Assets or business of
the Company;
(vii) any material inbound or outbound license for Intellectual Property owned or
licensed by the Company;
(viii) any Contract to which the Company is a party or by which the Company or any of
the Assets are bound for any material cleanup, abatement, investigation or other action in
connection with any release or threatened release of a Hazardous Material, the
22
payment of any existing material environmental Liabilities, or correction of any material
violation of Environmental Laws;
(ix) any Contract in which the Company has granted “most favored nation” pricing
provisions or exclusive marketing or distribution rights relating to any products or
territory or has agreed to purchase a minimum quantity of goods or services or has agreed to
purchase goods or services exclusively from a specified Person (or group of Persons);
(x) any Contract concerning the establishment or operation of a partnership, joint
venture or similar enterprise relating to the Company, or to which the Company is a party or
otherwise bound;
(xi) any Contract to which the Company is a party or by which the Company is bound
with any Governmental Authority;
(xii) any lease Contract relating to the Leased Real Property;
(xiii) each operating lease (as lessor or lessee) of tangible personal property
involving payments in excess of $250,000; and
(xiv) any Organizational Document of the Company.
(b) Except as set forth on Section 4.18(b) of the Seller Disclosure Schedule, (i) there
have been made available to Buyer true and complete copies of all of the Material Contracts
(including all amendments, modifications, extensions, renewals, guaranties and other related
agreements with respect thereto), (ii) all of the Material Contracts are legal, valid and binding
upon and enforceable against the Company and, to the Knowledge of Seller, the other parties
thereto, in accordance with their terms, (iii) the Company is not in default or breach in any
material respect under any Material Contract nor does any condition exist that with notice or lapse
of time or both would constitute such a default or breach thereunder by the Company, and, to the
Knowledge of Seller, no other party to any Material Contract is in default or breach in any
material respect of any Material Contract, nor does any condition exist that with notice or lapse
of time or both would constitute such a default or breach thereunder by any such party and (iv) the
Company has not received written notice that any party to any Material Contract intends to cancel
or terminate any such Material Contract or to not exercise any option to renew thereunder and, to
the Knowledge of Seller, no party to any Material Contract intends to exercise any right of
cancellation, termination, acceleration or modification under any such Material Contract.
4.19. Intellectual Property.
(a) Section 4.19(a) of the Seller Disclosure Schedule lists all registrations and
applications for registration of Intellectual Property that has been filed with or issued or
registered by a Governmental Authority and that is owned by the Company, including, as applicable,
the owner, the jurisdiction, the serial/application number, the patent or registration number, the
filing date, the issuance or registration date, the registrant and the registrar thereof. With
respect to each item required to be listed on Section 4.19(a) of the Seller Disclosure
23
Schedule, the Company is the sole owner or otherwise possesses all right, title and interest in and
to the item, free and clear of all Encumbrances (other than Permitted Encumbrances).
(b) The Company owns or otherwise has a right to use pursuant to Contracts that are valid and
enforceable against the Company and, to the Knowledge of Seller, the other parties thereto, in
accordance with their terms, all Intellectual Property necessary for or otherwise material to the
conduct of the Company’s business (collectively, the “Company Intellectual Property”);
provided, however, the foregoing representation and warranty shall not be deemed to be a
representation or warranty with respect to infringement, misappropriation, dilution or other
violation of any Intellectual Property rights of any other Person (which is covered in Section
4.19(c) below). Except as set forth on Schedule 4.19(b) of the Seller Disclosure Schedule, the
consummation of the transactions contemplated by this Agreement shall not result in the loss or
impairment of any material rights of the Company in any Company Intellectual Property.
(c) (i) The Company has not, since January 1, 2007, infringed, misappropriated, diluted or
otherwise violated any material Intellectual Property rights of any other Person, and (ii) except
as set forth on Section 4.19(c)(ii) of the Seller Disclosure Schedule, to the Knowledge of Seller,
no Person has, since January 1, 2007, infringed, misappropriated, diluted or otherwise violated any
material Intellectual Property rights of the Company.
(d) Except as set forth on Section 4.19(d) of the Seller Disclosure Schedule, with respect to
each item of Intellectual Property required to be listed on Section 4.19(a) of the Seller
Disclosure Schedule: (i) the item is not subject to any outstanding injunction, judgment, order,
decree, ruling or charge; (ii) no Action is pending or, to the Knowledge of Seller, threatened
which challenges the validity, enforceability, use or ownership of the item; and (iii) the item is
subsisting, has not been adjudicated as invalid or unenforceable and, to Seller’s Knowledge, there
are no facts or circumstances reasonably likely to give rise to such an adjudication. The Company
has used all commercially reasonable efforts to maintain, protect and enforce the material Company
Intellectual Property.
(e) Except for those trademarks set forth on Section 4.19(e) of the Seller Disclosure
Schedule, all of the trademarks and service marks owned or used by the Company and material to
the operation of its business are registered or subject to a pending application for registration
with the United States Patent and Trademark Office or the appropriate foreign agency.
(f) All past and present employees and independent contractors of, and consultants to, the
Company have entered into agreements pursuant to which such employee, independent contractor or
consultant agrees to protect the confidential information of the Company and, with respect to those
employees, independent contractors or consultants who contributed to the development of any
Intellectual Property for the Company, assign to the Company all Intellectual Property authored,
developed or otherwise created by such employee, independent contractor or consultant in the course
of his, her, or its employment or other relationship with the Company, without further
consideration or any restrictions or obligations on the use or ownership of such Intellectual
Property, and such agreements are valid and enforceable against the Company and, to the Knowledge
of Seller, the other parties thereto, in accordance with their terms.
24
(g) In the last twelve (12) months, there have been no failures, breakdowns, continued
substandard performance or other adverse events affecting any software, firmware, hardware,
networks, interfaces and platforms owned or used by the Company (the “Company Systems”)
that have caused or could reasonably be expected to result in a material disruption or interruption
in or to the use of the Company Systems and/or the conduct of the business of the Company.
(h) Except as set forth on Section 4.19(h) of the Seller Disclosure Schedule, (i) the
Company operates its business independently from Seller and its Affiliates (other than the
Company), and does not use and is not dependent on any facilities, resources, properties or Assets
of Seller or its Affiliates (other than the Company) and (ii) all Company Systems (other than
software) are owned by or under the control of the Company.
4.20. No Brokers. Except for Bank of America Xxxxxxx Xxxxx, the fees of which are the
sole responsibility of Seller, Seller has not engaged or made any agreement with any broker, finder
or similar agent or any Person or firm which will result in the obligation of Buyer or the Company
to pay any finder’s fee, brokerage fees or commission or similar payment in connection with the
transactions contemplated hereby. The engagement letter, dated as of November 6, 2009, between
Thoratec Corporation and Merrill, Lynch, Xxxxxx Xxxxxx & Xxxxx Incorporated does not include any
obligation on the part of the Company to engage Bank of America Xxxxxxx Xxxxx or any of its
Affiliates for any future services or any transaction (other than the transactions contemplated by
this Agreement) or any other obligation that will survive the Closing.
4.21. Absence of Changes. Except as set forth on Section 4.21 of the Seller Disclosure
Schedule, since January 2, 2010, (a) the business of the Company has been operated in the Ordinary
Course of Business, and (b) the Company has not taken any of the following actions:
(a) entered into or terminated any Material Contract, or extended, materially modified or
renewed any Material Contract (except for extensions and renewals at the end of the applicable term
of the Contract in the Ordinary Course of Business);
(b) sold, assigned, transferred, conveyed, leased, mortgaged, pledged or otherwise disposed of
or encumbered any material Assets of the Company, except for Permitted Encumbrances and
Encumbrances that have been released prior to the Closing;
(c) increased the compensation or benefits of any Company employee (except for increases in
salary or hourly wage rates, in the Ordinary Course of Business) or entered into any employment
agreement, severance agreement, or similar agreement or arrangement with any Company employee at
the “Vice President” level or higher or with any other Company employee whose annual base salary
exceeds $150,000 or any change in control agreement with any Company employee;
(d) (A) assumed, guaranteed, endorsed or otherwise become liable or responsible (whether
directly, contingently or otherwise) for any material Liabilities of any Person (other than in
connection with (I) Contracts entered into that are listed on Section 4.28 of the Seller
Disclosure Schedule and will be terminated in accordance with Section 4.28 or (II) Material
25
Contracts entered into since January 2, 2010 in the Ordinary Course of Business and which are
listed on Section 4.18(a) of the Seller Disclosure Schedule), (B) entered, made any loans, advances
or capital contributions to or investments in any Person (other than, with respect to loans and
advances, to employees in the Ordinary Course of Business in connection with travel or
entertainment expenses) or (C) incurred any Indebtedness;
(e) settled or compromised, or agreed to settle or compromise, any Action, other than
settlements or compromises of Actions involving solely money damages not in excess of $100,000
individually, or $300,000 in the aggregate;
(f) amended or modified any provision of its Organizational Documents;
(g) issued any Equity Interests; declared, set aside or made any payment or distribution
of Cash or other property with respect to its Equity Interests (other than any distribution
or similar action in accordance with the third sentence of Section 4.28); or purchased,
redeemed or otherwise acquired any of its Equity Interests;
(h) acquired (by merger, exchange, consolidation, acquisition of equity or Assets or
otherwise) any corporation, partnership, joint venture or other business organization or division
or the material Assets thereof (other than inventory or supplies in the Ordinary Course of
Business), or adopted a plan of complete or partial liquidation, dissolution, merger,
consolidation, restructuring, recapitalization or other reorganization of the Company;
(i) failed to file (or cause to be filed), on or prior to the due date thereof, all Tax
Returns required to be filed prior to the Closing Date for all Tax periods ending on or before the
Closing Date;
(j) made or changed any material Tax election other than in the Ordinary Course of
Business, adopted any accounting or Tax accounting method, changed any accounting or Tax accounting
method, entered into any closing agreement, settled any material Tax Claim or assessment or
consented to any material Tax Claim or assessment;
(k) directly or indirectly engaged in any material transaction with Seller, any of
Seller’s Subsidiaries, any other Person in which Seller holds, directly or indirectly, Controlling
Equity Interests or any of their respective directors or officers, except for those transactions
that will be terminated in accordance with Section 4.28;
(l) except as set forth in the Company’s capital expenditure budget (a copy of which is
attached to Section 4.21(l) of the Seller Disclosure Schedule), made capital expenditures (or any
commitment therefor) in excess of $100,000 in the aggregate, or failed to make any budgeted capital
expenditures in excess of $25,000 in the aggregate;
(m) (A) made any change with respect to the payment of accounts payable or accrued
expenses or the collection of the accounts receivable, including any acceleration or deferral of
the payment or collection thereof, as applicable, or (B) made any material change to the level of
inventories maintained by the Company;
26
(n) made any material change in the manner in which the Company extends discounts or
credits to customers;
(o) occupied or used any material facility or office or occupied or used any Company
Real Property in a manner materially different than such Company Real Property was occupied as of
January 2, 2010;
(p) other than the taking of any action required by this Agreement, engaged in any
employee layoff activities that would trigger the Worker Adjustment and Retraining Notification Act
of 1988, as amended, or any similar state or local plant closing or mass layoff statute, rule or
regulation;
(q) hired or terminated any management level employee having the title of Vice President
(or performing services ordinarily performed by a person having such title) or any management
level employee having a higher title;
(r) changed any accounting methods, principles or policies used by the Company or by
Seller with respect to the Company, unless required by GAAP or applicable Law;
(s) transferred, sold, assigned or licensed to any Person, or otherwise disposed of, or
incurred any Encumbrance on, any rights to the Company Intellectual Property material to the
business of the Company, other than in the Ordinary Course of Business or taken any action or
knowingly failed to take any action that would be reasonably likely result in the loss, lapse,
abandonment, invalidity or unenforceability of any patent or pending patent application of the
Company material to the business of the Company; or
(t) entered into any agreement, or otherwise became obligated, to do any of the
foregoing.
4.22. Unlawful Payments. Neither the Company, nor any Representative of the Company,
has directly or indirectly made any contribution, gift, bribe, rebate, payoff, influence payment,
kickback or other payment to any Person in respect of the Company’s business, private or public,
regardless of what form, in violation in any material respect of any applicable Law.
4.23. Affiliate Transactions. Except as set forth on Section 4.23 of the Seller
Disclosure Schedule and except for Contracts for the payment of wages, salaries, bonuses or other
compensation to officers or directors of the Company for services performed in the Ordinary Course
of Business (all of which are set forth on Section 4.23 of the Seller Disclosure Schedule), the
Company is not, and has not been during the last three (3) years, party to any Contract,
transaction or course of dealing with Seller, any of Seller’s Subsidiaries, any other Person in
which Seller holds, directly or indirectly, Controlling Equity Interests or any of their respective
directors or officers.
4.24. Significant Customers and Suppliers.
(a) (i) Section 4.24(a)(i) of the Seller Disclosure Schedule sets forth a true, complete
and correct customer list showing the ten (10) largest customers by revenues of the Company
27
during the twelve (12) month period ended on the date of the latest balance sheet included in the
Company Financial Statements (the customers described in the foregoing clause (i) being referred to
herein, individually, as a “Significant Customer” and, collectively, as the
“Significant Customers”), and (ii) Section 4.24(a)(ii) of the Seller Disclosure Schedule
sets forth a true, complete and correct supplier list showing (A) the ten (10) largest suppliers by
sales to the Company during the twelve (12) month period ended on the date of the latest balance
sheet included in the Company Financial Statements and (B) all suppliers of the Company (other than
suppliers covered by clause (A) above) who supply products that represented $100,000 in sales
during the twelve (12) month period ended on the date of the latest balance sheet included in the
Company Financial Statements and who are, to the Knowledge of Seller, potentially the sole source
to the Company of such supply (other than public utilities) (the suppliers described in clause (ii)
being referred to herein, individually, as a “Significant Supplier” and, collectively, as
the “Significant Suppliers”).
(b) Except as set forth on Section 4.24(b) of the Seller Disclosure Schedule, since
September 30, 2009, no Significant Customer or Significant Supplier has (i) stopped, or indicated
in writing an intention to stop, purchasing from or supplying the Company, (ii) materially reduced,
or indicated in writing an intention to materially reduce, its purchase of or provision of goods or
services to the Company, or (iii) changed, or indicated in writing an intention to change,
materially, the terms and conditions on which it is prepared to purchase from or supply the
Company. During the last three (3) months, no Significant Customer has indicated to the Company or
Seller in writing its intention to return products sold by the Company with a value in excess of
$100,000.
4.25. Insurance. Section 4.25 of the Seller Disclosure Schedule sets forth an accurate
list of all insurance policies carried by, or covering, the Company (the “Insurance
Policies”). The Company has delivered to Buyer true, complete and correct copies of all such
Insurance Policies. With respect to each such Insurance Policy: (a) such policy is legal, valid,
binding and enforceable in accordance with its terms and, except for policies that have expired
under their terms in the Ordinary Course of Business, is in full force and effect, (b) except as
set forth on Section 4.25(b) of the Seller Disclosure Schedule, neither Seller nor any Subsidiary
thereof, including the Company, is in breach or default (including any breach or default with
respect to the payment of premiums or the giving of notice) in any material respect, and no event
has occurred which, after notice or the lapse of time or both, would constitute a breach or default
or permit termination or modification, under such policy and (c) such policy is occurrence based.
All premiums due and payable under all such policies have been paid. To the Knowledge of Seller,
there have been no threatened terminations of, or material premium increases with respect to, any
such policies.
4.26. Warranties; Products. Except as set forth on Section 4.26 of the Seller
Disclosure Schedule, (i) no Claims have been made or are, to the Knowledge of Seller, threatened
under the Product Warranties, (ii) to the Knowledge of Seller, there exists no event or
circumstance, which after notice or the passage of time or both, might create or result in
Liabilities under any of the Product Warranties in excess of the Liabilities incurred under such
Product Warranties on average during the past two (2) years, (iii) there have been no statements,
citations or decisions by any Governmental Authority or any product testing laboratory stating that
any Customer
28
Offering is unsafe or fails to meet any standards promulgated by such Governmental Authority or
testing laboratory in any material respect, and (iv) there have not been any mandatory or voluntary
product recalls with respect to any Customer Offering and, to the Knowledge of Seller, there is no
fact relating to any Customer Offering that may impose a duty on the Company to recall any Customer
Offering.
4.27. Sufficiency of Assets. The tangible Assets constitute all of the tangible
Assets, rights and properties (including Owned Real Property and the Leased Real Property)
necessary and sufficient for the conduct of the Company’s business substantially in the same manner
as presently conducted.
4.28. Intercompany Arrangements. Section 4.28 of the Seller Disclosure Schedules sets
forth all Contracts of any kind (except for Contracts for the payment of wages, salaries, bonuses
or other compensation to officers or directors of the Company for services performed in the
Ordinary Course of Business (all of which are set forth on Section 4.23 of the Seller Disclosure
Schedule)) between Seller, any of Seller’s Subsidiaries, any other Person in which Seller holds,
directly or indirectly, Controlling Equity Interests (other than the Company) or any of their
respective directors or officers, on the one hand, and the Company, on the other hand, which have
been in effect at any time since January 1, 2010. All such Contracts have been terminated without
any payment by, Liability of or cost to Buyer or any Affiliate thereof, including the Company,
following the Closing. Seller has settled all receivables or payables, loans or other amounts due
or owed which were existing and outstanding at any time prior to the Closing between Seller, any of
Seller’s Subsidiaries, any other Person in which Seller holds, directly or indirectly, Controlling
Equity Interests (other than the Company) or any of their respective directors or officers, on the
one hand, and the Company, on the other hand.
4.29. No Implied Representations. Seller acknowledges that Buyer is making no
representation or warranty whatsoever, express or implied, beyond those expressly given in Article
V. Notwithstanding the foregoing, any Claims involving fraud, intentional misrepresentation or
willful misconduct on the part of Buyer or any of its Affiliates shall not be precluded, impacted
or otherwise affected by this Section 4.29.
ARTICLE V.
REPRESENTATIONS AND WARRANTIES OF BUYER
Buyer hereby represents and warrants to Seller as follows:
5.1. Organization. Buyer is a corporation duly organized, validly existing and in good
standing under the laws of the State of Delaware, with the requisite corporate power and authority
to conduct its business as it is presently being conducted. Buyer is duly qualified or licensed to
do business in each jurisdiction in which the property owned, leased or operated by Buyer or the
nature of the business conducted by Buyer makes such qualification necessary, except in any such
jurisdictions where the failure to be duly so qualified or licensed would not have a Material
Adverse Effect.
29
5.2. Authorization. Buyer has all requisite corporate power and authority and has
taken all corporate action necessary, to execute and deliver this Agreement and the other
agreements contemplated hereby, to consummate the transactions contemplated hereby and to perform
its obligations hereunder and thereunder. This Agreement and the other agreements contemplated
hereby have been duly executed and delivered by Buyer and, assuming the due authorization,
execution and delivery of this Agreement and such other agreements by Seller, are legal, valid and
binding obligations of Buyer, enforceable against Buyer in accordance with their respective terms,
except as may be limited by the effects of bankruptcy, insolvency, fraudulent conveyance,
reorganization, moratorium and other similar Laws relating to or affecting creditors’ rights
generally and general equitable principles (whether considered in a proceeding in equity or at
law).
5.3. Non-Contravention. Neither the execution and delivery of this Agreement or the
other agreements contemplated hereby, nor the consummation of the transactions contemplated hereby
or thereby, will (a) conflict with or result in a breach or violation of any provision of the
Organizational Documents of Buyer or, to the Knowledge of Buyer, any resolution of the board of
directors of Buyer, (b) violate or result in a default or breach of (or an event that with notice
or lapse of time or both would become a default or breach) or give rise to any right of
termination, modification, Consent or acceleration under, or result in the loss of any material
right or the imposition of any Liability under, any material Contract of Buyer, or (c) violate any
Law to which Buyer is subject.
5.4. Government Authorizations. No Consent of, with or to any Governmental Authority
is required to be obtained or made by Buyer in connection with the execution and delivery of this
Agreement or the consummation of the transactions contemplated hereby.
5.5. Litigation. There is no material Action pending or, to the Knowledge of Buyer,
threatened against Buyer that would have a Material Adverse Effect on Buyer.
5.6. No Brokers. Buyer has not engaged or made any agreement with any broker, finder
or similar agent or any Person or firm which will result in the obligation of Seller or any of its
Affiliates to pay any finder’s fee, brokerage fees or commission or similar payment in connection
with the transactions contemplated hereby.
5.7. Financing. Buyer has access to sufficient funds to consummate the transactions
contemplated by this Agreement and to satisfy all other costs and expenses arising in connection
herewith.
5.8. No Implied Representation. Buyer acknowledges that Seller is making no
representation or warranty whatsoever, express or implied, beyond those expressly given in Article
IV of this Agreement, including any implied warranty of merchantability or suitability as to the
properties or Assets of the Company. In addition, without limiting the generality of the foregoing,
Buyer acknowledges that any cost estimates, projections and predictions contained or referred to in
the materials that have been provided to Buyer are not and shall not be deemed to be
representations or warranties of Seller unless such matters are representations or warranties
covered in Article IV. Notwithstanding the foregoing, any Claims involving fraud, intentional
30
misrepresentation or willful misconduct on the part of Seller, the Company or any of their
respective Affiliates shall not be precluded, impacted or otherwise affected by this Section 5.8.
ARTICLE VI.
COVENANTS OF SELLER AND BUYER
Seller and Buyer each covenant with the other as follows:
6.1. Further Assurances. Each party hereto shall use its commercially reasonable
efforts to comply with all requirements imposed hereby on such party and to cause the transactions
contemplated herein (including, without limitation, the transfer of the Shares to Buyer) to be
consummated as contemplated herein and shall, from time to time and without further consideration,
either before or after the Closing, execute such further instruments and take such other actions as
any other party hereto shall reasonably request in order to fulfill its obligations under this
Agreement and to effectuate the purposes of this Agreement.
6.2. Material Contracts. If any Consent of a counterparty with respect to a Material
Contract of the Company is not obtained at the Closing, then at the request of Buyer, Seller shall
cooperate in any reasonable arrangement designed to obtain for Buyer the material economic benefits
and burdens of such Material Contract, solely for a period of six (6) months following the Closing
Date. Seller shall use commercially reasonable efforts to assist Buyer in providing notices and
otherwise taking actions required to transfer or reissue any Governmental Authorization as a result
of or in furtherance of the transactions contemplated by this Agreement and to cooperate with Buyer
to provide information necessary to apply for the transfer or reissuance of such Governmental
Authorization. Notwithstanding anything to the contrary in Section 6.5, Buyer and Seller shall,
after reasonable prior notice to and consultation with the other Party, be permitted to provide
confidential or proprietary information of the other Party to Governmental Authorities to the
extent necessary to transfer or reissue any Governmental Authorization.
6.3. ISRA. Seller shall, at Seller’s sole cost and expense, comply with and complete
all requirements and obligations imposed by ISRA arising out of the transactions contemplated by
this Agreement. Without limiting the generality of the forgoing, Seller shall make any filings,
provide any documents and execute any agreements necessary to obtain any Consents and approvals
that are necessary pursuant to ISRA for the consummation of the transactions contemplated hereby.
In the event that documentation confirming the completion of all applicable ISRA requirements, such
as a Response Action Outcome (as defined in ISRA), is not received prior to Closing, Seller shall
submit a Remediation Certification (as defined in ISRA) to the New Jersey Department of
Environmental Protection and post any required financial assurance necessary to allow the Closing
to occur prior to the completion of Seller’s remaining ISRA obligations. Seller shall then promptly
and expeditiously complete all applicable ISRA requirements, including any assessments,
investigation, or remediation that may be required. Seller may, at its option, elect to complete
its ISRA obligations through the use of institutional or engineering controls, such as a deed
notice or other restriction on future non-industrial or commercial use of the properties, provided
that such controls or use restrictions must (i) be
31
reasonably consistent with the current use of the properties immediately prior to Closing; (ii) not
entail material continuing operation or maintenance obligations; (iii) not materially interfere
with the continued non-residential use of the subject property; and (iv) with respect to any Leased
Real Property, is acceptable to the owner of such Leased Real Property. Buyer shall cooperate with
Seller and, after the Closing, shall cause the Company to cooperate with Seller with regard to
completion of Seller’s ISRA obligations hereunder including, (A) upon reasonable advance request of
Seller, providing Seller reasonable access to the relevant Company Real Property, personnel,
records and utility services; (B) taking commercially reasonable actions to not unreasonably
interfere with Seller’s ISRA investigations or remediation activities; (C) consenting to the
implementation of reasonable institutional or engineering controls and use restrictions consistent
with this paragraph; and (D) not taking actions (or failing to act) so as to knowingly exacerbate
any existing environmental conditions, create new environmental conditions or otherwise increase
the cost of Seller’s ISRA investigation or remediation activities. In completing its obligations,
Seller shall cooperate with Buyer, including: (I) Seller shall commence and perform its actions
promptly and without delay; (II) Seller shall not unreasonably interfere with Buyer’s operations at
the Company Real Property; (III) Seller shall keep Buyer apprised of its actions and shall share
draft and final copies of reports and filings; and (IV) Seller shall permit Buyer to reasonably
consult with Seller and Seller’s Licensed Site Remediation Professional, who shall in good faith
take into consideration the comments of Buyer. Seller shall indemnify Buyer with respect to any
Losses relating to or arising from the activities of Seller or its agents or contractors related to
its obligations as set forth in this Section 6.3.
6.4. Employee Matters.
(a) From and after the Closing Date and through December 31, 2010 (or such other date as is
expressly set forth in the Transition Services Agreement) (as applicable, the “Transition
Service Expiration Date”), and in accordance with and subject to the terms set forth in the
Transition Services Agreement, Company employees will, and Seller shall permit (and shall take all
reasonable action necessary to permit) all Company employees to, continue to participate in all
Benefit Plans listed on Schedule 6.4(a) of the Seller Disclosure Schedule (the “Health
and Welfare Benefit Plans”) in which they participated prior to the Closing Date; provided,
that with respect to any employee hired by the Company following the Closing Date and prior to the
Transition Service Expiration Date, such employee shall not have the right to participate in any
Health and Welfare Benefit Plan. Notwithstanding the foregoing provisions of this Section 6.4(a),
no Company employees shall have the right to participate in the Thoratec Corporation 401(k) Plan at
any time after the Closing.
(b) Except as otherwise provided in this Section 6.4 or in the Transition Services Agreement,
as of January 1, 2011, the Seller and the Company shall take such action as is necessary such that
the Company shall cease being a “participating employer” and shall cease any co-sponsorship and
participation in each Benefit Plan that is not a Company Benefit Plan (each such Benefit Plan being
a “Seller Plan”). The Company shall have no further Liability and the Seller shall retain all
Liabilities for Claims incurred under any Seller Plan (as determined under the terms of the Seller
Plans), whether such Claims are incurred prior to, on or after the Closing Date. Seller shall
provide under the Seller Plans any continuation coverage required under Section 4980B of the Code,
Part 6 of Title I of ERISA or applicable state Law
32
(“COBRA”) to each “qualified beneficiary” as that term is defined in COBRA whose
first “qualifying event” (as defined in COBRA) occurs on or prior to the Transition Service
Expiration Date.
(c) With respect to each employee benefit plan of Buyer or any Subsidiary thereof (each a
“Buyer Plan”), in which Company employees subsequently participate, for purposes of
determining vesting and entitlement to benefits, including for severance benefits and vacation
entitlement, service with the Company (or predecessor employers thereof) shall be treated as
service with the Person providing such Buyer Plan to the extent such service was taken into account
under any substantially similar plan in which any such Company employee participated immediately
prior to the Transition Service Expiration Date; provided, that such service shall not be
recognized to the extent that such recognition would result in a duplication of benefits. To the
extent permitted by each Buyer Plan, such Buyer Plan shall waive pre-existing condition limitations
and waiting periods with respect to participation and coverage requirements to the same extent such
limitations or waiting periods were inapplicable to, or had been satisfied by, such Company
employee immediately prior to the Transition Service Expiration Date under the analogous Benefit
Plan in which such Company employee participated. To the extent permitted by each Buyer Plan,
Company employees shall be given credit for amounts paid under a corresponding Benefit Plan during
the plan year in which the Closing occurs for purposes of applying deductibles, co-payments and
out-of-pocket maximums as though such amounts had been paid in accordance with the terms and
conditions of such Buyer Plan for the plan year in which the Closing occurs.
(d) Notwithstanding anything in this Agreement to the contrary, Seller will remain responsible
for the administration of, and shall pay (and Seller hereby covenants and agrees that it shall
ensure that neither Parent nor any other Buyer Indemnified Party shall have any Liability with
respect to) all amounts and other Liabilities that become payable or owing to any Person pursuant
to, the Thoratec Corporation Amended and Restated Nonqualified Deferred Compensation Plan, as
amended, prior to, upon or following the Closing.
(e) Nothing in this Section 6.4 shall create any third party beneficiary right in any Person
other than the Parties, including any current or former Company employee, any participant in any
Benefit Plan or Buyer Plan, or any dependent or beneficiary thereof, or any right to continued
employment with Buyer or any of its respective Affiliates. Nothing in this Section 6.4 shall
constitute an amendment to any Benefit Plan, Buyer Plan or any other plan or arrangement covering
Company employees and nothing in this Section 6.4 shall limit the ability of Buyer or its
Affiliates from amending the terms of, or terminating, any Benefit Plan, Buyer Plan or any other
plan or arrangement covering Company employees pursuant to the terms of such plan or arrangement.
The Company and Buyer shall each cooperate with the other and shall provide to the other such
documentation, information and assistance as is reasonably necessary to effect the provisions of
this Section 6.4, including the transition from the Benefit Plans to Buyer Plans following the
Transition Service Expiration Date.
33
6.5. Confidentiality.
(a) Each Party agrees that it shall not use any Confidential Information of any other Party or
its Affiliates for any purpose other than in connection with the consummation of the transactions
contemplated by this Agreement, whether or not consummated. The receiving Party will safeguard the
Confidential Information against disclosure by employing the same means to protect the Confidential
Information as it uses to protect its own non-public, confidential or proprietary information. Each
Party further agrees that it shall not divulge any such Confidential Information to any Person
except (i) to its employees, agents, lenders, financial and other advisors and Representatives to
the extent required in connection with the transactions contemplated by this Agreement, (ii) to the
extent provided in the next sentence, as required to comply with deposition, interrogatory, request
for documents, subpoena, civil investigative demand or similar process and (iii) as otherwise
agreed to by the Parties in writing. In the event that a Party becomes legally compelled (by
deposition, interrogatory, request for documents, subpoena, civil investigative demand or similar
process) to disclose any of the Confidential Information, such Party shall (to the extent permitted
by applicable Law) give the other Party prompt prior written notice of such requirement so that
they may seek a protective order or other appropriate remedy and/or waive compliance with the terms
of this Section 6.5. In the event that such protective order or other remedy is not obtained, or
that the Party waives compliance with the terms of this Section 6.5, the receiving Party agrees to
provide only that limited portion of the Confidential Information that it is advised by counsel is
legally required and to exercise reasonable best efforts to obtain assurance that confidential
treatment will be accorded such Confidential Information. Each Party shall inform its employees,
agents, lenders, financial and other advisors and Representatives of the confidential nature of
such information and the obligation to keep such information confidential, and shall take such
other action as shall be reasonably required to cause such information to be kept confidential. For
purposes of this Agreement, “Confidential Information” shall mean any non-public,
confidential or proprietary information, including any information relating to any Party or its
Affiliates’ properties or operations; provided, however, that Confidential Information shall not
include any information if:
(i) such information at the time of the disclosure or thereafter is generally
available to the public (other than as a result of a disclosure by the receiving Party in
violation of its confidentiality obligations set forth in this Section 6.5);
(ii) such information was available to the receiving Party on a non-confidential
basis from a source other than the other Party; provided, however that such source was not
known by the receiving Party to be bound by a confidentiality agreement or a duty of
confidentiality that protected the Confidential Information; or
(iii) such information has been independently acquired or developed without use of
Confidential Information by the receiving Party without violating any of its confidentiality
obligations hereunder.
(b) Notwithstanding the foregoing, following Closing, (i) Buyer shall not be prohibited from
disclosing to any Person any information relating to the Company, its business
34
or any Assets and (ii) with respect to Seller, the confidentiality obligations set forth in
Section 6.5 shall apply to any Confidential Information that Seller has that relates to the
Company, its business or any Assets.
6.6. Public Announcements. Except to the extent otherwise required by applicable Law
or the rules and regulations of each stock exchange upon which the securities of a Party (or an
Affiliate of such Party) are listed (and then only after consultation with Buyer or Seller, as
applicable) or in connection with any litigation commenced by any Party hereto against any other
Party hereto or any Affiliate thereof, none of the Parties will issue any press release or make any
other public announcements concerning the transactions contemplated hereby or the contents of this
Agreement without the prior written consent of the other Parties. If and to the extent that the
terms set forth in this Section 6.6 conflict with the terms of Section 6.5, the terms set forth in
this Section 6.6 shall control.
6.7. [Intentionally Omitted.]
6.8. Non-Competition; Non-Solicitation.
(a) Until the fifth anniversary of the Closing Date (the “Non-Competition
Period”), Seller shall not, and shall cause each of its Subsidiaries and any other Person in
which it holds, directly or indirectly, Controlling Equity Interests (such Persons, including their
respective successors or assigns, are collectively referred to herein as the “Restricted
Parties”), not to, directly or indirectly, form, own, manage, operate, join, control or
participate (whether as a partner, agent, representative, or otherwise) in the ownership,
management, operation or control of any Person in any territory in which the Company operates
immediately prior to Closing or has taken reasonable measures as of the Closing Date to begin
operating (the “Territory”), that, directly or indirectly competes with the business of the
Company as it shall exist immediately prior to the Closing Date (including only changes or
expansions in the business of the Company or the products sold or distributed by the Company that
are expressly contemplated as of the Closing (including, for the avoidance of doubt, the Alternate
Site Products)) (a “Competing Business”). In addition, during the Non-Competition Period,
neither Seller nor any Restricted Party shall have, without Buyer’s prior written consent, any
direct or indirect equity ownership in any such Person, other than as an owner of 2% or less of the
outstanding stock of a publicly traded corporation. For the avoidance of doubt, Seller and the
Restricted Parties shall not be restricted by the provisions of this Section 6.8 from acquiring
(whether through a purchase of stock or assets, through a merger or consolidation, or otherwise)
any Person that derives less than ten percent (10%) and less than $25,000,000 of its gross revenues
(as measured from the conclusion of any of such Person’s last three completed fiscal years) from
Competing Businesses in the aggregate; provided, however, that following an
acquisition permitted by this sentence, if such acquired Person derives more than twelve percent
(12%) or more than $30,000,000 of its gross revenues from Competing Businesses in the aggregate
during any fiscal year that ends during the Non-Competition Period, Seller or such Restricted Party
(as applicable) shall promptly provide written notice to Buyer of such fact and shall divest, as
soon as reasonably practicable (but in any event within twelve months of providing such notice), a
portion of the business of such Person that engages in Competing Businesses such that less than
twelve percent (12%) and less than $30,000,000 of such Person’s gross revenues would be derived
from
35
Competing Businesses during the remainder of the Non-Competition Period. Seller shall keep Buyer
informed, on a reasonably current basis and in reasonable detail, of the status of Seller’s efforts
to divest such business (or portion thereof) in accordance with the preceding proviso and Buyer
shall have the right to participate as a potential purchaser in the sale process for such business
(or portion thereof) on terms at least as favorable as those being offered to other participants in
the sale process.
(b) Until the third anniversary of the Closing Date, Seller shall not, and shall cause each of
the Restricted Parties not to, directly or indirectly, for itself or on behalf of any Person, (i)
solicit for employment or hire any Company employee; provided, however that any such employee may
seek employment with the applicable Person in response to a general advertisement not directed at
such employee and the applicable Person may hire any employee who responds to such general
advertisement; (ii) approach any supplier or licensee of the Company with respect to products or
services it provided to the Company at any time during the twelve-month period prior to the Closing
with the intention of harming the business or operations of the Company by causing such Person to
decrease or cease doing business with the Company; or (iii) approach any Person who is a customer
of the Company at any time during the twelvemonth period prior to the Closing with the intention of
harming the business or operations of the Company by causing such Person to purchase the products
of any business competitive with the Company.
(c) Seller acknowledges that the provisions set forth in this Section 6.8 are an integral part
of the success of the Company throughout the Territory. If, on or after the Closing Date, Seller or
any Restricted Party utilizes its reputation and goodwill in competition with Buyer, Buyer will be
deprived of the benefits it has bargained for pursuant to this Agreement. In the event that the
agreements in this Section 6.8 shall be determined by any court of competent jurisdiction to be
unenforceable by reason of extending for too great a time or over too great a geographical area or
by reason of it being too extensive in any other respect, it shall be interpreted to extend only
over the maximum period of time for which it may be enforceable and/or over the maximum
geographical area as to which it may be enforceable and/or to the maximum extent in all other
respects as to which it may be enforceable, all as determined by such court in such action.
(d) If Seller or any Restricted Party breaches or threatens to commit a breach of any of the
restrictive covenants set forth in this Section 6.8, then the Company and Buyer shall each have the
following rights and remedies against Seller or such Restricted Party, each of which shall be
independent of the others and severally enforceable, and each of the following rights and remedies
is in addition to, and not in lieu of, any other rights and remedies otherwise available to any of
them at Law or in equity: the right and remedy to have the restrictive covenants in this Section
6.8 specifically enforced against the Seller or such Restricted Party, including temporary
restraining orders and injunctions by any court of competent jurisdiction, it being agreed by
Seller that any breach or threatened breach by Seller or any Restricted Party of this Section 6.8
would cause irreparable injury to the Company and Buyer and that money damages would not provide an
adequate remedy to the Company or Buyer.
36
(e) Each of Seller and Buyer intends that the covenants set forth in Sections 6.8(a) and
6.8(b) shall be deemed to be a series of separate covenants, one for each county or province of
each and every state, territory or jurisdiction within the Territory, and one for each month of the
time periods covered by such covenants.
(f) Seller hereby agrees that in the event a court of competent jurisdiction declares there
has been a breach by Seller or any Restricted Party of Section 6.8(a) or Section 6.8(b), the term
of any such covenant so breached shall be automatically extended beyond its intended expiration for
a period of time equal to the duration of such breach.
(g) Seller shall be responsible for any breach of this Section 6.8 by any of its Subsidiaries
or any other Person in which Seller holds, directly or indirectly, Controlling Equity Interests.
6.9. [Intentionally Omitted].
6.10. Insurance. Buyer shall be solely responsible for providing insurance to the
Company for any event or occurrence after the Closing. Without limiting the rights of Buyer set
forth elsewhere in this Agreement, if any Claims may reasonably be made, or if Losses have occurred
prior to the Closing Date that relate to the Company, and such Claims may be made against insurance
policies retained by Seller or its Affiliates, then Seller (on behalf of itself and its Affiliates)
shall, at Buyer’s request and at Buyer’s sole cost and expense, use its reasonable best efforts in
an effort to permit Buyer (after the Closing Date and in cooperation with Seller) to file, notice
and otherwise continue to pursue such Claims and recover proceeds under the terms of such policies,
and, subject to all of the foregoing, Seller (on behalf of itself and its Affiliates) agrees (at
Buyer’s sole cost and expense) to otherwise reasonably cooperate with Buyer or its Affiliates to
make the benefits of any such insurance policies available to Buyer or its Affiliates.
6.11. Checks Payable; Payroll; Cash.
(a) From and after the Closing, Seller shall remain liable for and shall honor and pay (and
Seller hereby covenants and agrees that it shall ensure that neither Parent nor any other Buyer
Indemnified Party shall have any Liability with respect to) any and all checks or other instruments
of payment written or issued on or prior to the Closing Date by Seller or ITC, in each case that
have not been settled or otherwise satisfied on or prior to the Closing Date and that relate to the
business or operations of ITC.
(b) On or as soon as practicable following the Closing Date, Seller shall pay (and Seller
hereby covenants and agrees that it shall ensure that neither Parent nor any other Buyer
Indemnified Party shall have any Liability with respect to) the payroll of ITC otherwise due and
payable November 5, 2010.
(c) Any Cash or checks received by the Company on November 3, 2010 in the total amount of less
than or equal to two hundred and twenty-five thousand dollars ($225,000) shall be maintained by the
Company for the benefit of the Buyer following the Closing and shall not be distributed by the
Company to Seller, provided, that in the event that the Company receives Cash
37
or checks in excess of two hundred and twenty-five thousand dollars ($225,000) on such date, Seller
may cause the Company to distribute such excess amount to Seller.
6.12. Cooperation; Financial Reporting. Buyer agrees to furnish or cause to be
furnished, upon written request, information and assistance of employees of the Company relating to
the pre-Closing operation of the business of the Company as is necessary in the reasonable judgment
of Seller in order for Seller (i) to satisfy on a timely basis its financial reporting obligations
related to the Company pursuant to the Exchange Act until the date of
filing of Seller’s 10-K for
the 2010 fiscal year of Seller and (ii) from the date of filing of Seller’s 10-K for the 2010
fiscal year of Seller until two (2) years from such date, to satisfy any other legitimate legal
obligation (as determined by Seller in good faith) or financial reporting obligation of Seller
relating to the pre-Closing operation of the business of the Company and identified to Buyer in
writing. The obligations of Buyer pursuant to clause (i) above shall include access at reasonable
times within normal business hours to all books and records of the Company relating to the
pre-Closing operation of the business of the Company as may be reasonably requested by Seller and
the assistance of all personnel of the Company, who, in the Ordinary Course of Business of the
Company as of the date hereof, perform services or otherwise aid Seller with respect to such
reporting obligations; provided, that in no event shall such access or assistance unreasonably
interfere with the operation of the Company’s business or the duties of such personnel to the
Company. The obligations of Buyer pursuant to clause (ii) above shall include access at reasonable
times within normal business hours to the specific books and records of the Company required for
the purpose specified by Seller in its request for such services and the assistance of certain
personnel of the Company to be mutually agreed between Buyer and Seller; provided, that in no event
shall such access or assistance unreasonably interfere with the operation of the Company’s business
or the duties of such personnel to the Company. Buyer shall be obligated to provide the services
set forth in clauses (i) and (ii) at a cost to Seller consistent with the hourly rates of the
employees performing such services (or, if such employees are salaried employees, at a reasonable
approximation of such employee’s per hour salary) and Seller shall reimburse Buyer for all
out-of-pocket expenses incurred by Buyer or the Company in providing such services. For the
avoidance of doubt, cooperation obligations related to Taxes are addressed solely in Section 10.4.
In no event shall Buyer or the Company or any of their respective Affiliates have any Liability in
respect of any reasonable act or omission of any employee of the Company with respect to the
performance of the services contemplated by this Section 6.12 or otherwise in connection with any
information provided to Seller by Buyer, the Company or any Affiliate thereof pursuant to the terms
set forth in this Section 6.12. All Confidential Information of either Party of which the other
Party becomes aware during the provision of the services contemplated by this Section 6.12 shall be
treated in accordance with Section 6.5. Notwithstanding anything to the contrary in this Agreement,
(A) Buyer shall not be required to take any action pursuant to this Section 6.12 if there is a
legitimate business reason for not taking such action, as determined in good faith by Buyer, and
(B) Buyer need not supply Seller with any access or information which Buyer or any of its
Affiliates is under a legal or contractual obligation not to supply.
6.13. Title Insurance and Surveys. With respect to the Owned Real Property, Seller
shall use commercially reasonable efforts to assist Buyer (at Buyer’s sole cost and expense) in
obtaining title insurance policies and surveys in form and substance satisfactory to Buyer,
38
including removing from title any Encumbrances (other than Permitted Encumbrances). Seller shall
provide Buyer’s title company with any affidavit, indemnity or other assurances reasonably
requested by such title company in order to issue such title insurance policies.
ARTICLE VII.
[INTENTIONALLY OMITTED]
ARTICLE VIII.
[INTENTIONALLY OMITTED].
ARTICLE IX.
SURVIVAL AND INDEMNIFICATION
9.1. Survival.
(a) Each and every representation and warranty contained in this Agreement (other than the
Surviving Representations and Warranties) shall expire as of the Closing. Each Specified
Representation and Warranty shall survive the Closing Date until the date that is twelve (12)
months from the Closing Date and then expire. Each Fundamental Representation and Warranty shall
survive the Closing Date until sixty (60) days following the expiration of the longest applicable
statute of limitation applicable to such Fundamental Representation and Warranty, or underlying
Claims that may constitute a breach thereof.
(b) Each and every covenant contained in this Agreement (other than the covenants contained in
this Agreement which by their terms are to be performed (in whole or in part) by the Parties
following the Closing, including, for the avoidance of doubt, those set forth in Section 6.12 and
Section 11.8 hereof (collectively, the “Surviving Covenants”)) shall expire with, and be
terminated by, the Closing; and none of Seller, Buyer or any Representative or Affiliate of any of
them shall have any Liability whatsoever with respect to any such covenant following the Closing.
Each Surviving Covenant shall survive the Closing Date until, and will expire sixty (60) days
following the expiration of the statute of limitation applicable to such covenant. The
indemnification obligations of Seller set forth in Section 9.2(a)(iii) shall survive the Closing
Date until sixty (60) days following the expiration of the statute of limitations that is
applicable to the applicable Pre-Closing Tax which may be subject to indemnification pursuant to
Section 9.2(a)(iii). The indemnification obligations of Seller set forth in Section 9.2(a)(iv)
shall survive the Closing until the date that is five (5) years from the Closing Date and then
expire. The indemnification obligations of Seller set forth in Section 9.2(a)(v) shall expire on
the twelve (12) month anniversary of the Closing Date.
(c) Any representation, warranty or covenant in respect of which indemnity may be sought under
this Article IX (including, without limitation, covenants to provide indemnification
pursuant to Sections 9.2(a)(iii), 9.2(a)(iv) and 9.2(a)(v)), and the indemnity obligations of the
applicable Party with respect thereto, shall survive the time at which it would otherwise terminate
pursuant to this Section 9.1 if written notice of the Claim giving rise to such right or
39
potential right of indemnity shall have been given to the Party against whom such indemnity may be
sought prior to such time and, in any such case, such representation, warranty or covenant and the
indemnification obligations with respect thereto shall survive until any Claim (and any Claim
arising out of similar facts and circumstances) for indemnity related thereto is settled or fully
resolved.
9.2. Indemnification.
(a) From and after the Closing, Seller shall indemnify, defend (subject to Section
9.2(c)) and hold harmless the Buyer Indemnified Parties from and against any and all Losses
incurred, suffered or sustained by any Buyer Indemnified Party in connection with, arising out of
or resulting from (directly or indirectly): (i) any breach of any Surviving Representation and
Warranty and any Third Party Claim alleging facts that, if true, would constitute such a breach of
any Surviving Representation and Warranty; (ii) any breach of any Surviving Covenant by Seller;
(iii) any Pre-Closing Taxes; (iv) any Claim by any Person who was an officer, director or
stockholder of the Company, or the holder of a stock option, restricted stock, restricted stock
unit, or other equity award relating to Seller’s common stock, at any time prior to the Closing,
which Claim is made in such capacity, to the extent such Claim does not arise from any action of
Buyer Indemnified Parties after the Closing; and (v) the occurrence of any FDA Event.
(b) From and after the Closing, Buyer shall indemnify, defend (subject to Section
9.2(c)) and hold harmless the Seller Indemnified Parties from and against any and all Losses
incurred, suffered or sustained by any Seller Indemnified Party in connection with, arising out of
or resulting from (directly or indirectly): (i) any breach of any representation or warranty made
by Buyer in Article V and any Third Party Claim alleging facts that, if true, would constitute such
a breach of any representation or warranty; and (ii) any breach of any Surviving Covenant by Buyer.
(c) If a Claim for Losses is to be made by a Party entitled to indemnification hereunder with
respect to any Claim or other assertion of Liability by a third party (a “Third Party
Claim”), the Party claiming such indemnification shall give written notice (a “Claim
Notice”) to the indemnifying Party as soon as reasonably practicable after the Party entitled
to indemnification becomes aware of any fact, condition or event which may give rise to Losses for
which indemnification may be sought under this Section 9.2 with respect to any Third Party Claim;
provided, however, if any Action is filed against any Party entitled to the benefit of and seeking
indemnity hereunder for a Third Party Claim, the applicable Claim Notice shall be given to the
indemnifying Party within twenty (20) Business Days after the service of the citation or summons
(the “Notice Period”). Notwithstanding the foregoing, the failure of any indemnified Party
to give timely notice hereunder shall not affect rights to indemnification hereunder, except and
only to the extent that the indemnifying Party is actually and materially prejudiced by such
failure. The Parties understand and agree that the failure of the indemnified Party to so notify
the indemnifying Party prior to settling any such Third Party Claim (whether by paying the Third
Party Claim or executing a binding settlement agreement with respect thereto) shall constitute
actual and material prejudice to the indemnifying Party’s ability to defend against such Third
Party Claim; provided, that the indemnified Party is hereby authorized (but not obligated) prior to
and during the Notice Period to file any motion, answer or other pleading and to take any
40
other action which the indemnified Party shall deem necessary or appropriate to protect the
indemnified Party’s interests. After receiving a Claim Notice, the indemnifying Party shall be
entitled, upon written notice to the indemnified Party, at its own cost, risk and expense, (i) to
take control of the defense and investigation of such Action, (ii) to employ and engage attorneys
of its own choice (reasonably acceptable to the indemnified Party) to handle and defend the same
(unless the named parties to such Action include both the indemnifying Party and the indemnified
Party, and the indemnified Party has been advised by counsel that (A) there may be one or more
legal defenses available to such indemnified Party that are different from or additional to those
available to the indemnifying Party or (B) there are issues that raise actual or likely conflicts
of interest between the indemnifying Party and the indemnified Party, in which event the
indemnified Party shall be entitled, at the indemnifying Party’s cost, risk and expense, to
separate counsel of its own choosing) and (iii) to compromise or settle such Third Party Claim,
which compromise or settlement shall be made only with the prior written consent of the indemnified
Party, such consent not to be unreasonably withheld or delayed; provided, however, that the
indemnifying Party shall not be entitled to assume control of such defense and shall pay the fees
and expenses of counsel retained by the indemnified Party, if (1) the indemnifying Party does not
agree in writing to be fully responsible for all Losses relating to such Third Party Claim; (2) the
Third Party Claim involves a Governmental Authority; (3) the Third Party Claim relates to or arises
in connection with any criminal Action; or (4) the Third Party Claim seeks equitable relief or any
other non-monetary remedy against the indemnified Party. In the event the indemnifying Party takes
control of the defense and investigation of such a Claim, the indemnified Party may, at its own
cost and expense, participate in the investigation, trial and defense of such Action and any appeal
arising therefrom (it being understood that the indemnifying Party shall control such defense). If
the indemnifying Party fails to assume the defense of such Third Party Claim within fifteen (15)
Business Days after receipt of the Claim Notice, the indemnified Party against which such Third
Party Claim has been asserted will (upon delivering notice to such effect to the indemnifying
Party) have the right to undertake, at the indemnifying Party’s cost and expense, the defense,
compromise or settlement of such Third Party Claim on behalf of and for the account and risk of the
indemnifying Party. Any Third Party Claim the defense of which is assumed by an indemnified Party
shall not be compromised or settled without the prior written consent of the indemnifying Party,
which consent shall not be unreasonably withheld or delayed. In the event the indemnified Party
assumes the defense of a Third Party Claim, the indemnified Party will keep the indemnifying Party
reasonably informed of the progress of any such defense, compromise or settlement. The Parties
shall cooperate in all reasonable respects with each other in the investigation, trial and defense
of any Third Party Claim for Losses or Action and any appeal arising therefrom.
(d) If an indemnified Party asserts a Claim which does not involve a Third Party Claim,
the indemnified Party shall provide a Claim Notice to the indemnifying Party prior to the
expiration of the relevant survival period specified in Section 9.1. If the indemnifying party does
not notify the indemnified Party within twenty (20) Business Days of its receipt of the Claim
Notice that the indemnifying Party disputes such Claim, the amount of such Claim shall be
conclusively deemed a liability of the indemnifying Party hereunder. If the indemnifying Party
makes an objection in writing (which such writing must include a reasonable description of the
indemnifying Party’s basis for such objection(s)), the indemnified Party shall have fifteen (15)
Business Days to respond in a written statement to the objection(s). If after such fifteen (15)
41
Business Day period there remains a dispute as to any such Claim, the Parties shall attempt in good
faith for twenty (20) Business Days to agree upon the rights of the respective Parties with respect
to such Claim. If the Parties should so agree, a memorandum setting forth such agreement shall be
prepared and signed by both Parties. If such Parties shall not agree, an indemnified Party shall be
entitled to initiate an Action and seek remedies as may be permitted under the terms of this
Agreement.
(e) In the event of payment in full by the indemnifying Party to the indemnified Party in
connection with any Claim (an “Indemnified Claim”), the indemnifying Party shall be
subrogated to and shall stand in the place of the indemnified Party as to any events or
circumstances in respect of which the indemnified Party may have any right or Claim relating to
such Indemnified Claim against any claimant or plaintiff asserting such Indemnified Claim or
against any other Person. The indemnified Party shall cooperate with the indemnifying Party in a
reasonable manner, and at the cost and expense of the indemnifying Party, in prosecuting any
subrogated right or Claim.
(f) The Parties shall reasonably cooperate with each other with respect to resolving any Claim
or Liability with respect to which one Party is obligated to indemnify another Party hereunder,
including, at the written request of, and at the sole cost and expense of, the indemnifying Party,
using commercially reasonable efforts to mitigate any such Claim or Liability.
(g) For purposes of determining whether there has been a breach of any representation or
warranty contained in this Agreement, or the amount of any Loss related to a breach of any
representation or warranty contained in this Agreement, the representations and warranties
contained in this Agreement shall be considered without regard to any “material,” “Material Adverse
Effect” or similar qualifications contained therein. The representations, warranties and covenants
contained in this Agreement shall not be affected by any investigation, inquiry or examination made
for or on behalf of any Party, or the knowledge of any Party of a breach of any representation,
warranty or covenant by the other Party.
9.3. Limitations on Indemnification.
(a) Except as provided in the penultimate sentence of this Section 9.3(a),
notwithstanding anything to the contrary contained in this Agreement, (i) no indemnification under
Section 9.2(a)(i) or Section 9.2(a)(v) hereof shall be made by Seller and no indemnification under
Section 9.2(b)(i) hereof shall be made by Buyer, and neither Seller nor Buyer shall have any
Liability, respectively, to the other therefor, unless and until the aggregate amount of Losses
subject to indemnification pursuant thereto and due the Party being indemnified shall exceed
$1,000,000 (the “Threshold Amount”), and once the Threshold Amount is exceeded the
indemnifying Party shall indemnify the indemnified Party, and shall be liable, only for the amount
of any such Losses in excess of the Threshold Amount; (ii) the aggregate amount required to be paid
by Seller pursuant to its indemnification obligations under Section 9.2(a)(i) hereof or by Buyer
pursuant to its indemnification obligations under Section 9.2(b)(i) hereof shall not exceed an
amount equal to $5,500,000 (which, for purposes of calculating this amount, (x) excludes the
Threshold Amount and (y) includes all amounts paid by Seller pursuant
42
to its indemnification obligations under Section 9.2(a)(v)), and neither Party shall have any
Liability to any indemnified Party for, and such indemnified Parties shall have no right to recover
from Seller or Buyer, as the case may be, any amount of Losses pursuant to such indemnification
obligations which exceeds (and from and after the time such Losses exceed) such amount; (iii) no
indemnification under Section 9.2(a)(i) hereof shall be made by Seller and no indemnification under
Section 9.2(b)(i) hereof shall be made by Buyer, and neither Seller nor Buyer shall have any
Liability, respectively, to the other for any individual Claim or any Liability arising out of or
resulting from a single action, event, occurrence or a set of circumstances, unless such individual
Claim or such Liability arising out of or resulting from a single action, event, occurrence or a
set of circumstances is greater than $37,500; provided, that in the case of clause (iii)
above, any Claims or Liabilities resulting from similar facts or circumstances shall be aggregated
for the purposes of determining whether such Claims or Liabilities are indemnifiable pursuant to
such clause; and (iv) Seller’s indemnification obligations pursuant to Section 9.2(a)(v) shall not
exceed an amount equal to $7,000,000 (which, for purposes of calculating this amount, shall be
deemed to include all amounts paid by Seller pursuant to its indemnification obligations under
Section 9.2(a)(i), whether or not related to an FDA Event). Notwithstanding anything set forth
herein to the contrary, the applicable indemnified Party shall be entitled to indemnification
without regard to any of the provisions of this Section 9.3(a) with respect to (1) indemnification
obligations for Losses relating to any breach (and any Third Party Claim alleging facts that, if
true, would constitute such a breach) of (x) the Fundamental Representations and Warranties, or (y)
any of the Specified Representations and Warranties set forth in the last sentence of Section
4.9(a), or in Section 4.21(l), or in Section 4.21(m), (2) Claims of fraud, intentional
misrepresentation or willful breach of this Agreement, or (3) Claims pursuant to Section
9.2(a)(ii), 9.2(a)(iii), 9.2(a)(iv) or Section 9.2(b)(ii); provided, however, that the
aggregate Liability (other than with respect to Claims for fraud, intentional misrepresentation or
willful breach of this Agreement) of Seller or Buyer under Section 9.2(a) (other than under Section
9.2(a)(iii) or under Section 9.2(a)(ii) in respect of the Surviving Covenants set forth in Sections
6.4, 6.5 or 6.8) and Section 9.2(b), respectively, shall in no event exceed the Purchase Price.
(b) To the extent that any Losses or Claim therefor which is subject to indemnification
hereunder are covered by insurance held by any indemnified Party (an “Insured Loss”), such
indemnified Party shall only be entitled to indemnification pursuant to Section 9.2 hereof with
respect to the amount of Losses in excess of the net cash proceeds actually received by such
indemnified Party pursuant to such insurance (after deducting the out-of-pocket costs and expenses
incurred in connection with obtaining such proceeds, excluding incremental insurance premium
costs). With respect to any Insured Loss, the applicable indemnified Party shall first use all
commercially reasonable efforts to obtain the maximum recovery from the provider of such insurance
and then, to the extent that the net cash proceeds received by such indemnified Party (after
deducting the out-of-pocket costs and expenses incurred in connection with obtaining such proceeds,
excluding incremental insurance premium costs) are less than the amount of the Losses indemnified
hereunder, or if the indemnified Party is unable to promptly obtain full recovery from such
provider, the indemnified Party shall be entitled to seek indemnification pursuant to Section 9.2
hereof with respect to the amount of the Losses that exceed such recovery, if any; provided,
however, that if, following the receipt of any indemnity payments pursuant to Section 9.2 hereof,
the indemnified Party obtains any insurance recovery
43
from a third party insurance provider, with respect to such Losses, then such indemnified Party
shall promptly pay over to the indemnifying Party (in proportion to their relative payments in
respect of the underlying Loss) the amount of the net cash proceeds received by such indemnified
Party pursuant to such insurance (after deducting the out-of-pocket costs and expenses incurred in
connection with obtaining such proceeds, excluding incremental insurance premium costs) up to, but
not in excess of, the amount of the indemnity payments made by the indemnifying Party pursuant to
such Losses. The Parties agree that (i) no insurance company shall have any right of subrogation
under this Section 9.3(b), (ii) this Section 9.3(b) is not for the benefit of any third party
insurance provider and (iii) this Section 9.3(b) shall not require any indemnified Party to
initiate, engage in or threaten litigation with any of its insurance carriers.
(c) Except for (i) equitable relief, including, without limitation, injunctive relief or
specific performance, to which either Party hereto may be entitled pursuant to other Sections of
this Agreement, and (ii) Claims of fraud, intentional misrepresentation or willful breach of this
Agreement, the indemnification provided in this Article IX and Section 10.3 shall be the sole and
exclusive remedy of the Parties for monetary damages for any breach of any representation, warranty
or covenant contained in this Agreement.
(d) Notwithstanding anything to the contrary in this Agreement, Losses indemnifiable under
this Article IX hereof shall expressly exclude punitive damages, except for any such Losses arising
out of Third Party Claims (which shall be indemnifiable by the indemnifying Party for all such
damages).
(e) Notwithstanding anything to the contrary herein, Seller shall not be obligated to
indemnify, defend and hold harmless the Buyer Indemnified Parties from and against any Losses
incurred, suffered or sustained by any Buyer Indemnified Party in connection with, arising out of
or resulting from any breach of the representations or warranties made by Seller in Section 4.15
where the matter giving rise to such Losses is discovered as a result of any Buyer Indemnified
Parties conducting sampling and analysis of soil or groundwater at any Company Real Property after
the Closing Date, except to the extent such sampling is: (i) required by Environmental Laws,
including a permit issued pursuant to Environmental Laws; (ii) required by a Governmental Order;
(iii) reasonably necessary to investigate identified conditions that indicate an imminent or
substantial endangerment to health or the environment; (iv) reasonable to defend against or
otherwise respond to a Third Party Claim; (v) with respect to Leased Real Property, necessary to
comply with the requirements of the lease agreement pertaining to such Leased Real Property; (vi)
requested in writing by a lender or prospective purchaser in connection with a sale, lease,
financing or mortgage involving any Company Real Property; or (vii) conducted in connection with
proposed construction or expansion at any the Company Real Property, to the extent such sampling is
consistent with industry practice, provided, that for the avoidance of doubt, the indemnification
of any Buyer Indemnified Parties shall not be limited by any Buyer Indemnified Party conducting
sampling or analysis of any drinking water or production water xxxxx that may exist on the Closing
Date at any Company Real Property, or of any wastewater discharges at any Company Real Property, or
of any indoor or outdoor air at any Company Real Property.
44
ARTICLE X.
TAX MATTERS
10.1. Preparation of Tax Returns.
(a) Seller shall, at its own expense, prepare and timely file all Tax Returns of or including
the Company for any Pre-Closing Taxable Period or Straddle Period required to be filed after the
Closing Date which Tax Returns also include Seller or any other Subsidiary thereof (such Tax
Returns, “Seller Group Returns”) and shall timely pay any Taxes due in respect of such
Seller Group Returns. Such Seller Group Returns shall be prepared consistent with past practice,
except as otherwise required by Law. Solely as relates to the Company, a copy of each such Seller
Group Return shall be delivered to Buyer at least 5 Business Days prior to the filing of such
Seller Group Return for Buyer’s review and reasonable comment.
(b) Buyer shall, at its own expense, prepare consistently with past practice (except as
otherwise required by Law) and timely file all other Tax Returns of or relating to the Company for
any Pre-Closing Taxable Period or Straddle Period required to be filed after the Closing Date (such
Tax Returns, “Separate Company Returns”) and shall timely pay any Taxes due in respect of
such Separate Company Returns, subject to Buyer’s indemnification rights under Section 9.2 hereof.
A copy of each such Separate Company Return shall be delivered to Seller at least 15 days prior to
the due date of such Separate Company Return for Seller’s review and approval (which approval shall
not be unreasonably withheld, conditioned or delayed), and all reasonable comments of Seller shall
be reflected on such Separate Company Returns prior to filing.
(c) Neither Buyer nor any of its Affiliates shall (or shall cause or permit the Company or any
of its Subsidiaries to) file, amend, refile or otherwise modify any Tax Return relating in whole or
in part to the Company with respect to any Pre-Closing Taxable Period (or with respect to any
Straddle Period) without the prior written consent of Seller, which consent shall not be
unreasonably withheld, conditioned or delayed.
(d) Seller shall be entitled to the amount of any refund or credit of Pre-Closing Taxes, which
refund or credit is actually realized by Buyer or its Subsidiaries (including the Company) after
the Closing, net of any Tax cost to Buyer and its Subsidiaries as a result of the receipt of such
refund or credit. Buyer shall pay, or cause to be paid, to Seller any amount to which Seller is
entitled pursuant to the prior sentence within two Business Days of the receipt or recognition of
the applicable refund or credit by Buyer or its Subsidiaries. To the extent requested by Seller,
Buyer will reasonably cooperate with Seller in obtaining such refund or credit, including through
the filing of amended Tax Returns for periods ending before or on the Closing Date or refund
claims. To the extent such refund or credit is subsequently disallowed or required to be returned
to the applicable Governmental Authority, Seller agrees to repay the amount of such refund or
credit, together with any interest, penalties or other additional amounts imposed by the applicable
Governmental Authority, to Buyer.
(e) Notwithstanding anything in this Agreement to the contrary, Buyer and Seller agree that,
for income tax reporting purposes, (i) the vesting in connection with the Closing of
45
restricted stock units of Seller held by employees or former employees of the Company, and any
payments made to such employees or former employees in respect of such vesting, shall be deemed to
occur immediately prior to the Closing and shall be allocable to the Pre-Closing Tax Period for all
tax reporting purposes, and any payroll Taxes associated with such vesting shall be treated as a
Pre-Closing Tax notwithstanding the last sentence of the definition of “Pre-Closing Taxes”; (ii)
deductions arising from the vesting in connection with the Closing of restricted stock of Seller
held by employees or former employees of the Company shall be allocable to the Tax period of the
Company beginning after the Closing Date, and any payroll Taxes associated with such vesting shall
not be treated as a Pre-Closing Tax; and (iii) deductions arising from the exercise after the
Closing Date by employees or former employees of the Company of options to purchase Seller stock
shall be allocable to the Tax period of the Company beginning after the Closing Date, and any
payroll Taxes associated with such vesting shall not be treated as a Pre-Closing Tax.
10.2. Transfer Taxes. All sales, use, transfer, stamp, registration, documentary,
excise, real property transfer, or similar Taxes incurred as a result of the transactions
contemplated by this Agreement shall be borne 50% by Buyer and 50% by Seller.
10.3. Cooperation; Taxes. Buyer and Seller agree to furnish or cause to be furnished
to the other, upon request, as promptly as practicable, such information and assistance relating to
Taxes, including, without limitation, access to books and records, as is reasonably necessary for
the filing of all Tax Returns, the making of any election relating to Taxes, the preparation for
any audit by any taxing authority and the prosecution or defense of any Claim, suit or proceeding
relating to any Tax. Each of Buyer and Seller shall retain all books and records with respect to
Taxes for a period of at least seven (7) years following the Closing Date.
10.4. Tax Treatment of Indemnification Payments. Any indemnification payments made
pursuant to Article 9 shall be treated as adjustments to the Purchase Price for Tax purposes.
10.5. Tax Claims. Notwithstanding anything in this Agreement to the contrary, Seller
shall have sole control of the conduct and defense of any audits, disputes, proceedings and Claims
involving a Governmental Authority with respect to Pre-Closing Taxes (a “Tax Claim”);
provided, however, that Seller shall (i) keep Buyer reasonably informed of material developments of
the progress of such Tax Claim and (ii) shall not settle or compromise such Tax Claim without the
prior written consent of Buyer, not to be unreasonably withheld, conditioned or delayed, in each of
(i) and (ii) to the extent such Tax Claim relates to a Straddle Period or the resolution of such
Tax Claim could reasonably be expected to materially and adversely affect the liability of Buyer or
its Affiliates for Taxes (taking into account Seller’s indemnification obligations hereunder). In
the event of any conflict between this Article X and the provisions of Article IX, the provisions
of this Article X shall control.
ARTICLE XI.
MISCELLANEOUS
11.1. [Intentionally Omitted].
46
11.2. Assignment; Successors and Assigns; No Third Party Rights.
(a) Neither this Agreement nor any of the rights or obligations hereunder may be assigned by
any Party (by Contract, operation of Law or otherwise) without the prior written consent of the
other Party; provided, that Buyer may, without the prior written consent of Seller, assign any or
all of its rights and obligations under this Agreement to one or more of its Affiliates, but no
such assignment shall relieve Buyer of its obligations hereunder, and any Party may assign any or
all of their respective rights or obligations to any third party who subsequently purchases all or
substantially all of the equity or Assets of such Party. Notwithstanding anything else herein to
the contrary, it is expressly agreed that the express assumption by the receiving, acquiring,
leasing, surviving or successor Person(s) (on a joint and several basis with the relevant Party
hereto) of all of the obligations of any Party hereto shall be a condition precedent to the
transfer, sale, lease, assignment or other disposition of all or a substantial portion of the
business, operations or Assets (including on a consolidated basis with its Subsidiaries) of such
party, by way of asset sale, equity sale, merger, consolidation, liquidation, dissolution,
recapitalization, operation of Law or otherwise, and that further such assumption shall be deemed
to occur automatically to the maximum extent permitted by applicable Law.
(b) Subject to the foregoing, this Agreement shall be binding upon and inure to the benefit of
the Parties hereto and their respective successors and permitted assigns. Except as expressly
provided in Article IX, nothing in this Agreement, express or implied, is intended to or shall
confer upon any Person other than the parties to this Agreement and their successors and permitted
assigns any rights, benefits or remedies of any nature whatsoever under, or by reason of, this
Agreement. No third party is entitled to rely on any of the representations, warranties and
agreements contained in this Agreement. Buyer and Seller assume no liability to any third party
because of any reliance on the representations, warranties and agreements of Buyer or Seller
contained in this Agreement.
(c) Buyer hereby accepts each indemnity under Section 9.2 in favor of each of the other Buyer
Indemnified Parties, as agent and trustee of such indemnified party, and Buyer may enforce such
indemnities on behalf of that indemnified party. Seller agrees that it accepts each indemnity under
Section 9.2 in favor of each of the other Seller Indemnified Parties, as agent and trustee of such
indemnified party, and Seller may enforce such indemnities on behalf of that indemnified party.
11.3. Specific Performance. Each Party acknowledges and agrees that the Parties would
be damaged irreparably in the event any provision of this Agreement is not performed in
accordance with its specific terms or is otherwise breached, so that, in addition to any other
remedy that a Party may have under law or equity, each Party shall be entitled to injunctive
relief
to prevent breaches of the provisions of this Agreement and to enforce specifically this
Agreement and the terms and provisions hereof. Each of the Parties hereto hereby waives (i)
any
defense that a remedy at law would be adequate in any action for specific performance and (ii)
any requirement under any applicable law to post a bond or other security as a prerequisite to
obtaining equitable relief.
47
11.4. Notices. All notices, requests, demands and other communications which are
required or may be given under this Agreement shall be in writing and shall be deemed to have been
duly given (a) when received if personally delivered, (b) when transmitted if transmitted by
telecopy, electronic mail or other digital transmission, (c) the day after it is sent, if sent for
next day delivery to a domestic address by recognized overnight delivery service and (d) upon
receipt, if sent by certified or registered mail, return receipt requested. In each case any such
notice, request, demand or other communication shall be sent to:
If to Seller, to:
Thoratec Corporation
0000 Xxxxxxxxxx Xxxxx
Xxxxxxxxxx, XX 00000
Attention: Xxxxx Xxxxxx, General Counsel
Facsimile: (000) 000-0000
Email: xxxxx.xxxxxx@xxxxxxxx.xxx
0000 Xxxxxxxxxx Xxxxx
Xxxxxxxxxx, XX 00000
Attention: Xxxxx Xxxxxx, General Counsel
Facsimile: (000) 000-0000
Email: xxxxx.xxxxxx@xxxxxxxx.xxx
with copies (which shall not constitute notice) to:
Xxxxxx & Xxxxxxx LLP
000 Xxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attention: Xxxxxxx X. Xxxx, Esq., Xxx Xxxxxx, Esq.
Facsimile: (000) 000-0000
Email: xxxxxxx.xxxx@xx.xxx, xxx.xxxxxx@xx.xxx
000 Xxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attention: Xxxxxxx X. Xxxx, Esq., Xxx Xxxxxx, Esq.
Facsimile: (000) 000-0000
Email: xxxxxxx.xxxx@xx.xxx, xxx.xxxxxx@xx.xxx
If to Buyer, to:
c/o Warburg Pincus LLC
000 Xxxxxxxxx Xxx
Xxx Xxxx, Xxx Xxxx 00000
Attention: Xxxx Xxxxx
Fax: (000) 000-0000
000 Xxxxxxxxx Xxx
Xxx Xxxx, Xxx Xxxx 00000
Attention: Xxxx Xxxxx
Fax: (000) 000-0000
with a copy (which shall not constitute notice) to:
Xxxxxxx Xxxx & Xxxxxxxxx LLP
000 Xxxxxxx Xxxxxx
Xxx Xxxx, XX 00000
Attention: Xxxxxxx X. Xxxx
000 Xxxxxxx Xxxxxx
Xxx Xxxx, XX 00000
Attention: Xxxxxxx X. Xxxx
Xxxxxxx X. Leaf
Facsimile: (000) 000-0000
Email: xxxxx@xxxxxxx.xxx
Email: xxxxx@xxxxxxx.xxx
xxxxx@xxxxxxx.xxx
48
or to such other place and with such other copies as either Party may designate as to itself by
written notice to the other.
11.5. Governing Law. THIS AGREEMENT, AND ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION
(I) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR (II) IN ANY WAY CONNECTED WITH OR RELATED OR
INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT OR ANY OF THE
TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND
WHETHER IN CONTRACT, TORT, EQUITY OR OTHERWISE, SHALL BE CONSTRUED, INTERPRETED AND THE RIGHTS OF
THE PARTIES DETERMINED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK (WITHOUT REFERENCE TO
THE CHOICE OF LAW PROVISIONS THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAWS OF
THE STATE OF NEW YORK).
11.6. Entire Agreement; Amendments and Waivers. This Agreement (together with the
Seller Disclosure Schedule) and the other agreements being entered into concurrently herewith
(including the Transition Services Agreement) constitute the entire agreement among the Parties
pertaining to the subject matter hereof and thereof and supersede all prior agreements,
understandings, negotiations and discussions with respect to such subject matter, whether oral or
written, of the Parties, including, without limitation, the Confidentiality Agreement (except any
provisions of the Confidentiality Agreement relating to the non-solicitation obligations of Buyer).
This Agreement may not be amended, supplemented or modified and no provision hereof may be waived
except, in the case of an amendment, supplement or modification, by an instrument in writing signed
on behalf of each of the Parties hereto, and in the case of a waiver, by the Party waiving rights
hereunder. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute
a waiver of any other provision hereof (whether or not similar), nor shall such waiver constitute a
continuing waiver unless otherwise expressly provided.
11.7. Counterparts. This Agreement may be executed in one or more counterparts, each
of which shall be deemed an original, and all of which together shall constitute one and the same
instrument, binding upon the Parties hereto. The execution of this Agreement by any of the Parties
may be evidenced by way of a facsimile transmission of such Party’s signature, a photocopy of such
facsimile transmission or other electronic means, and such facsimile or other electronic signature
shall be deemed to constitute the original signature of such Party hereto.
11.8. Expenses. Except as otherwise specified in this Agreement, each Party hereto
shall pay its own legal, accounting, out-of-pocket and other expenses (including investment banking
fees or expenses) incurred in connection with, arising out of or incident to this Agreement and the
transactions contemplated hereby, including, without limitation, any action taken by such Party in
preparation for carrying this Agreement into effect (“Transaction Expenses”);
provided, however, that no Transaction Expenses shall be incurred by, or allocated
by Seller to, the Company, and neither the Company, Parent or any other Buyer Indemnified Party
shall have any Liability for (and Seller hereby covenants and agrees that it shall pay, and shall
ensure that
49
neither Parent nor any other Buyer Indemnified Party shall have any Liability with respect to) any
Transaction Expenses of the Company.
11.9. Severability. In the event that any one or more of the provisions contained in
this
Agreement or in any other instrument referred to herein, shall, for any reason, be held to be
invalid, illegal or unenforceable in any respect, then to the maximum extent permitted by Law,
such invalidity, illegality or unenforceability shall not affect any other provision of this
Agreement or any other such instrument.
11.10. Titles; Gender; Certain Interpretive Matters. The titles, captions or headings
of the Articles and Sections herein, and the use of a particular gender, are for convenience of
reference only and are not intended to be a part of or to affect or restrict the meaning or
interpretation of this Agreement. Any of such terms, unless the context otherwise requires, may be
used in the singular or plural, depending upon the reference. All references in this Agreement to
Dollars or “$” shall mean U.S. Dollars. The term “this Agreement” means this Stock Purchase
Agreement together with all annexes, the Seller Disclosure Schedule and exhibits hereto, as the
same may from time to time be amended, modified, supplemented or restated in accordance with the
terms hereof. The use in this Agreement of the term “including” means “including, without
limitation.” The words “herein,” “hereof,” “hereunder” and other words of similar import refer to
this Agreement as a whole, including the annexes, the Seller Disclosure Schedule and exhibits
hereto, and not to any particular section, subsection, paragraph, subparagraph or clause contained
in this Agreement. Where specific language is used to clarify by example a general statement
contained herein, such specific language shall not be deemed to modify, limit or restrict in any
manner the construction of the general statement to which it relates. To the extent that this
Agreement requires the Company to take or omit to take any action prior to Closing, such agreement
and obligations includes the obligation of Seller to cause the Company to take or omit to take such
actions. In the event an ambiguity or question of intent arises, this Agreement shall be construed
as if drafted jointly by the Parties, and no presumption or burden of proof shall arise favoring or
disfavoring any Party by virtue of the authorship of any of the provisions of this Agreement.
11.11. Seller Disclosure Schedule; Construction of Certain Provisions. No exceptions
to any representations or warranties disclosed in one particular section of the Seller Disclosure
Schedule shall constitute an exception to any other representations or warranties made in Article
IV of this Agreement unless the exception is disclosed as provided herein on each such other
applicable section of the Seller Disclosure Schedule or cross-referenced in such other applicable
section of the Seller Disclosure Schedule or unless the applicability of such exception to another
section of the Seller Disclosure Schedule is reasonably apparent on its face. It is understood and
agreed that the specification of any dollar amount in the representations and warranties contained
in this Agreement or the inclusion of any specific item in the Seller Disclosure Schedule is not
intended to imply that such amounts or higher or lower amounts, or the items so included or other
items, are or are not material, and no Party shall use the fact of the setting of such amounts or
the fact of the inclusion of any such item in the Seller Disclosure Schedule in any dispute or
controversy between the Parties as to whether any obligation, item or matter not described herein
or included in the Seller Disclosure Schedule is or is not material for purposes of this Agreement.
50
No parol evidence of any nature shall be used in the construction or interpretation of this
Agreement.
11.12. Service of Process, Consent to Jurisdiction; WAIVER OF JURY TRIAL.
(a) Each Party hereto irrevocably consents to the service of any process, pleading, notices or
other papers by the mailing of copies thereof by registered, certified or first class mail, postage
prepaid, to such Party at such Party’s address set forth herein, or by any other method provided or
permitted under New York law.
(b) Except as set forth in Section 6.8, any Claim, demand, Action or cause of action (i)
arising out of or relating to this Agreement or (ii) in any way connected with or related or
incidental to the dealings of the Parties hereto in respect of this Agreement or any of the
transactions contemplated hereby, in each case whether now existing or hereafter arising, and
whether in contract, tort, equity or otherwise, shall be instituted exclusively in the federal
court for the Southern District of New York, or, if such court does not take or have jurisdiction
over such Claim, in any New York state court in the county of New York having jurisdiction over
such Claim, and each Party hereto agrees not to assert, by way of motion, as a defense or
otherwise, in any such Claim, that it is not subject personally to the jurisdiction of any such
court, that the Claim is brought in an inconvenient forum, that the venue of the Claim is improper
or that this Agreement or the subject matter hereof may not be enforced in or by any such court.
Each Party hereto further irrevocably submits to the jurisdiction of any such court in any such
Claim.
(c) EACH PARTY TO THIS AGREEMENT HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY
RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION (I) ARISING UNDER THIS
AGREEMENT OR (H) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES
HERETO IN RESPECT OF THIS AGREEMENT OR ANY OF THE TRANSACTIONS RELATED HERETO, IN EACH CASE WHETHER
NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. EACH PARTY
TO THIS AGREEMENT HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION, OR CAUSE OF
ACTION WILL BE DECIDED BY TRIAL WITHOUT A JURY AND THAT THE PARTIES TO THIS AGREEMENT MAY FILE AN
ORIGINAL COUNTERPART OR A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT
OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.
11.13. Independence of Agreements, Covenants, Representations and Warranties. All
agreements and covenants hereunder shall be given independent effect so that if a certain
action
or condition constitutes a default under a certain agreement or covenant, the fact that such
action
or condition is permitted by another agreement or covenant shall not affect the occurrence of
such default. In addition, all representations and warranties hereunder shall be given
independent effect so that if a particular representation or warranty proves to be incorrect
or is
breached, the fact that another representation or warranty concerning the same or similar
subject
51
matter is correct or is not breached will not affect the incorrectness of or a breach of a
representation and warranty hereunder.
[Signature page follows]
52
IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be duly
executed on their respective behalf, by their respective officers thereunto duly
authorized, all as of the day and year first above written.
Seller: THORATEC CORPORATION |
||||
By: | /s/ Xxxxxxx X. Xxxxxxx | |||
Name: | Xxxxxxx X. Xxxxxxx | |||
Title: | President and Chief Executive Officer | |||
Buyer: ITC NEXUS HOLDING COMPANY, INC. |
||||
By: | /s/ Xxxx Xxxxx | |||
Name: | Xxxx Xxxxx | |||
Title: | Director | |||
[Signature Page to Stock Purchase Agreement]
EXHIBIT A
Form of Transition Services Agreement
Execution Version
TRANSITION SERVICES AGREEMENT
THIS TRANSITION SERVICES AGREEMENT, dated as of November 4, 2010 (together with all Schedules
hereto, as the same may from time to time be amended, modified, supplemented or restated in
accordance with the terms hereof, this “Agreement”), is by and between International
Technidyne Corporation, a Delaware corporation (the “Company”), and Thoratec Corporation, a
California corporation (“Seller” or “Thoratec”). All capitalized terms used herein but not
otherwise defined shall have the meanings given to them in the Purchase Agreement (as defined
below).
W I T N E S S E T H :
WHEREAS, Seller and ITC Nexus Holding Company, Inc., a Delaware corporation
(“Buyer”), are parties to that certain Stock Purchase Agreement, dated as of even date
herewith (as the same may be amended, modified or supplemented from time to time in accordance
with its terms, the “Purchase Agreement”); and
WHEREAS, in connection with the transactions contemplated by the Purchase Agreement and
pursuant to Section 3.3(a) thereof, Seller and Buyer agreed to enter into this Agreement on the
terms and subject to the conditions set forth herein.
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties hereto hereby agree as follows:
1. Provision of Services. Subject to the terms and conditions of this Agreement,
during the Term (as defined in Section 5), Seller agrees to provide to the Company all of
the services set forth on Schedule I attached hereto (collectively all of the services
provided by Seller hereunder, the “Services”). Seller shall not be required to perform a
Service if the provision of such Service by Seller conflicts with or violates applicable law;
provided that Seller uses commercially reasonable efforts to promptly resolve the conflict
or violation, and provide such Services to the Company promptly thereafter. Any costs incurred in
connection with any such resolution will be paid in accordance with Section 3.
2. Standard of Performance. Seller shall provide to the Company the Services
substantially to the same extent, substantially for the same purposes, in substantially the same
manner, with substantially the same degree of care (which in no event may be less than reasonable
care) as Seller has provided such Services to the Company during the twelve-month period prior to
the date hereof; provided, that at all times the Services shall be performed in a timely,
efficient, and workmanlike manner; provided, further, that in no event shall
Seller have any Liability to the Company in respect of any reasonable act or omission of any
employee of Seller with respect to the performance of the Services. The Company shall use the
Services substantially to the same extent, substantially for the same purposes and in
substantially the same manner as the Company used the Services during the twelve-month period
prior to the date hereof. During the Term of this Agreement with respect to Health and Welfare
Benefits Services as set forth in Section 5(a)(i), the Company will not terminate in
excess of twenty employees of the Company covered by such Health and Welfare Benefits Services
provided by Seller.
3. Fees; Payment Terms.
(a) Except
as set forth in Section 5, the cost to the Company for each Service shall
be the cost to Seller of providing such Service (which includes any out-of-pocket expenses incurred
by Seller relating thereto as set forth on Schedule I, provided, for the avoidance of
doubt, except with respect to the Audit Services set forth on
Schedule I, such cost shall
not include any salary, benefits or other compensation paid to employees of Seller providing such
Services). The Company shall also pay all applicable federal, state, local and foreign stamp,
sales, use, privilege, service, value-added, excise or other Taxes paid or payable by Seller in
connection with providing the Services (excluding U.S. federal, state, local or foreign income or
franchise Taxes imposed on the net income of Seller) (“Covered Taxes”). In addition, all
fees for Services shall be paid without any deduction or withholding for Covered Taxes unless such
deduction or withholding is required by law. If such deduction or withholding is required by law,
the amounts payable by the Company hereunder will be increased so that after giving effect to all
such deductions or withholdings (including upon such increased amounts) Seller receives the same
net amount Seller would have received had no such deduction or withholding been required.
(b) The Company shall pay Seller:
(i) | with respect to Services set forth on Schedule I under the headings “Health and Welfare Benefits”, “Life Insurance Benefits” and “Benefits for EU Employees” (the “Employee Benefits Services”), $410,000 (the “Estimated Monthly Service Fee”) on the first day of each calendar month during the Term following the Closing Date for Employee Benefits Services to be received by the Company from Seller during the forthcoming thirty (30) day period; provided, that no later than thirty (30) days after the end of the Term as set forth in Section 5(a)(i), Seller shall submit statements of account to the Company with respect to the cost for all Employee Benefits Services provided to the Company during the Term, provided, that the cost for such Employee Benefits Service for any portion of the month in which the Closing occurs shall be reduced by all amounts prepaid by Seller or the Company with respect to such benefit plans subject of the Employee Benefits Services (the “Benefit Invoiced Amount”), and if the sum of the Estimated Monthly Service Fees paid by the Company to Seller during the Term is (x) less than the Benefits Invoiced Amount, the Company shall pay Seller for any amounts underpaid within thirty (30) days of the Company’s receipt of the statement for the Benefits Invoiced Amount, and (y) more than the Benefits Invoiced Amount, Seller shall reimburse the Company for any amounts overpaid within thirty (30) days of delivery of the statement for the Benefits Invoiced Amount to the Company; | ||
(ii) | with respect to Services set forth on Schedule I under the heading “Audit Support” (“Audit Services”), the amount set forth on the statement of account that Seller submits to the Company each month with respect to all Audit Services delivered during the preceding month (the “Audit Services |
2
Invoiced Amount”), such undisputed Audit Services Invoiced Amounts shall be paid by the Company within thirty (30) days after receipt of such statements; | |||
(iii) | with respect to Services set forth on Schedule I under the heading “Payroll Services” (“Payroll Services”), (A) with respect to the international employees of the Company, the amount set forth on the statement of account that Seller submits to the Company within five (5) business days after each payroll date of the Company with respect to such international employees Payroll Services (the “International Payroll Services Invoiced Amount”), such undisputed International Payroll Services Invoiced Amounts shall be paid by the Company promptly upon, and in no event later than five (5) business days from the date of, the Company’s receipt of the statement for such International Payroll Services Invoiced Amount, and (B) with respect to the domestic employees of the Company, four (4) business days prior to the payroll date (for the avoidance of doubt, on Monday for a Friday payroll date), such amount as determined by the Company based on the preliminary payroll calculation prepared by the Company in good faith (the “Preliminary Payroll Calculation”); provided, that if the sum of the Preliminary Payroll Calculation is (x) less than the final payroll calculation provided by ADP to the Company (the “Final Payroll Calculation”), the Company shall pay Seller for any amounts underpaid three (3) business days prior to the payroll date, and (y) more than the Final Payroll Calculation, Seller shall reimburse the Company for any amounts overpaid three (3) business days prior to the payroll date; | ||
(iv) | with respect to Services set forth on Schedule I under the headings “Telephony” (“Telephony Services”). “Networking Services and Domain Services” (“Networking Services”) and “Licenses, Contracts and Detailed IT Separation Plan” (“Licensing Services” and together with Telephony Services and Networking Services, the “IT Services”), the amount set forth on the statement of account that Seller submits to the Company each month for each such Service (the “IT Services Invoiced Amount”), such undisputed IT Services Invoiced Amounts shall be paid by the Company within thirty (30) days after receipt of such statements; and | ||
(v) | with respect to Services set forth on Schedule I under the heading “Treasury Services” (the “Treasury Services”), the amount set forth on the statement of account that Seller submits to the Company within thirty (30) days after the end of the Term for each such Service (the “Treasury Services Invoiced Amount” and together with the Benefits Invoiced Amount, the Audit Services Invoiced Amount, the International Payroll Services Invoiced Amount and the IT Services Invoiced Amount, the “Invoiced Amounts”), such undisputed Treasury Services Invoiced Amounts shall be paid by the Company within thirty (30) days after receipt of such statements. |
3
The Company shall pay the Estimated Monthly Service Fees and Invoiced Amounts to Seller by
wire transfer of immediately available funds to an account designated by Seller. In the event that
the Company does not pay Seller the Estimated Monthly Service Fees and Invoiced Amounts in
accordance with this Section 3, all amounts so payable and past due shall accrue interest
until paid at a rate equal to the Prime Rate unless disputed in accordance with this Section
3. Notwithstanding the foregoing, in the event the Company disagrees with the Invoiced Amounts,
the Company shall send written notice to Seller within thirty (30) days of the Company’s receipt of
the Invoiced Amount specifying the reason for such disagreement, and Seller and the Company will
negotiate in good faith to promptly resolve any such disagreement. Seller agrees to afford the
Company, upon reasonable notice, access to such information, records and documentation of Seller as
the Company may reasonably request in order to verify the Invoiced Amount.
4. Tax Withholding on Option Exercises. In the event that an employee or former
employee of the Company exercises an option to purchase Seller common stock for which tax
withholding obligations will be incurred by the Company during the Term, then as soon as
administratively practicable following such exercise Seller shall remit an amount to the Company
equal to such tax withholding obligations. The Company will bear the amount of the employer
portion of any employment tax obligations incurred as a result of such exercise. The Company
agrees to remit all such amounts to the appropriate taxing authorities. Upon request, the Company
agrees to promptly provide such information as may be necessary for Seller to calculate any such
withholding amounts.
5. Term; Termination.
(a) Unless
this Agreement is earlier terminated pursuant to Section 5(b) below, the
term of this Agreement shall be for a period commencing on the date hereof and terminating on the
date that is 90 days after the date hereof (the “Term”); provided, that with
respect to any (i) Employee Benefits Services, the Term shall terminate on the last day of the
calendar month on or following the 60th day following the date hereof; (ii) Payroll
Services for domestic employees, the Term shall terminate following the completion of the first
payroll cycle following the Closing Date, (iii) Treasury Services, this Agreement shall terminate
with respect to such Services on the date that is 120 days following the Closing Date, and (iv)
Audit Services, this Agreement shall terminate with respect to such Services on the date that is 6
months following the last day of the current fiscal year of Buyer.
(b) If either party hereto causes or suffers to exist any material breach of any of its
obligations under this Agreement, including any failure to perform any Services (except to the
extent excused pursuant to Section 16) or to make undisputed payments when due, and such
party does not cure such breach within thirty (30) days after receiving written notice thereof
from the non-breaching party, the non-breaching party may terminate this Agreement, including the
provision of Services pursuant hereto, immediately by providing written notice of termination;
provided, however, that during the pendency of any uncured breach relating to the provision of a
Service, the Company shall not be required to pay the fee related to such Service during such
period. The failure of a party to exercise its rights hereunder with respect to a breach by the
other party shall not be construed as a waiver of such rights nor prevent such Party from
subsequently asserting such rights with regard to the same or similar defaults.
4
6. Effect
of Termination; Termination Assistance; Survival.
(a) Upon termination or expiration of this Agreement:
(i) | all rights under this Agreement to receive the expired or terminated Service(s) will cease (for the avoidance of doubt, upon termination of this Agreement, all Services will cease to be provided); | ||
(ii) | Seller and the Company each shall return, or cause to be returned, to the other any of the other party’s Confidential Information that is in the returning party’s possession or control and shall destroy, or cause to be destroyed, all copies (including electronic versions) of any compilations, analyses, studies or other documents prepared by the returning party containing or reflecting any such Confidential Information; and | ||
(iii) | the Company’s obligation to pay Seller for expired or terminated Services will cease (other than for Services rendered prior to such expiration or termination). |
(b) During the Term, Seller shall, at the Company’s expense, provide such cooperation to the
Company as may reasonably be requested by the Company and as is necessary for the Company to
transfer responsibility for the provision of the Services to the Company or a new provider (the
“Termination Services”. Notwithstanding anything to the contrary, any Termination Services
will be invoiced to the Company monthly in arrears, and shall be payable by the Company within
thirty (30) days of delivery of such invoice for the Termination
Services (a “Termination Services Invoice”). Notwithstanding the foregoing, if the Company disagrees
with any amount set forth in the Termination Services Invoice, the Company shall send written
notice to Seller within thirty (30) days of the Company’s receipt of the Termination Services
Invoice specifying the reason for such disagreement, and Seller and the Company will negotiate in
good faith to promptly resolve any such disagreement. Seller agrees to afford the Company, upon
reasonable notice, access to such information, records and documentation of Seller as the Company
may reasonably request in order to verify any amount set forth in the Termination Services
Invoice.
(c) Section 3 (solely with respect to Services rendered prior to such expiration or
termination), Section 8 through Section 19 and this Section 6 will survive
expiration or termination of this Agreement: The remaining provisions shall survive to the extent
required for any Termination Services.
7. Cooperation; Access; Consents.
(a) Each of the parties hereto agrees to fully cooperate in good faith with the other in
connection with the Services provided under this Agreement. Each of the parties hereto shall take
such actions, upon the request of the other party, as may be necessary or reasonably appropriate
to implement or give effect to this Agreement.
(b) Seller shall permit the Company and its employees and agents reasonable access during
regular business hours upon reasonable prior notice to (i) individuals responsible
5
for the Services and (ii) such data and records relating to the Services as the Company may
reasonably request for the purposes of allowing the Company to exercise general oversight and to
monitor the performance of the Services.
(c) The Company shall make available on a timely basis to Seller all information, systems,
materials and data reasonably requested by Seller to enable it to provide the Services. Upon
reasonable prior notice from Seller, the Company shall give Seller reasonable access during
regular business hours and at such other times as are reasonably required to the premises of the
Company’s business for the purposes of providing the Services.
8.
Confidentiality; Data.
(a) Seller and the Company shall, and shall cause each of their respective Affiliates,
officers, directors, employees and advisors to, hold all non-public information relating to the
business of the other party disclosed to such person in connection
with this Agreement (“Confidential Information”) confidential and will not use such Confidential Information
except as necessary to perform its obligations under this Agreement or in connection with the
Termination Services and will not disclose any of the Confidential Information to any Person other
than a party’s Affiliates, directors, officers, employees, representatives (including, without
limitation, financial advisors, attorneys and accountants), agents or in the case of Seller any
Person to whom it delegates any responsibilities under this Agreement
pursuant to Section 2, unless legally compelled to disclose such information; provided, however, that to
the extent the receiving party may become so legally compelled they may only disclose such
Confidential Information if they shall first have used commercially reasonable efforts to, and, if
practicable and legally permissible, shall have afforded the disclosing party the opportunity to,
obtain an appropriate protective order or other satisfactory assurance of confidential treatment
for the Confidential Information required to be so disclosed.
(b) The term Confidential Information shall not include information that (i) is or becomes
generally available to the public other than as a result of a disclosure by the receiving party or
(ii) is or becomes available to the receiving party on a nonconfidential basis from a source other
than the disclosing party that is not prohibited from disclosing such information by a legal,
contractual or fiduciary obligation.
9.
NO WARRANTY; LIMITATION OF LIABILITY.
(a) EXCEPT AS SET FORTH IN SECTION 2, SELLER MAKES NO EXPRESS OR IMPLIED REPRESENTATIONS OR
WARRANTIES WITH RESPECT TO THE SERVICES, INCLUDING, WITHOUT LIMITATION, ANY WARRANTY OF
MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.
(b) SELLER SHALL NOT BE LIABLE, WHETHER IN CONTRACT, IN TORT (INCLUDING NEGLIGENCE AND
STRICT LIABILITY), OR OTHERWISE, FOR ANY SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, EXEMPLARY
OR PUNITIVE DAMAGES WHATSOEVER THAT IN ANY WAY ARISE OUT OF, RELATE TO, OR ARE A CONSEQUENCE OF,
ITS PERFORMANCE OR NONPERFORMANCE HEREUNDER, OR THE PROVISION OF OR FAILURE TO PROVIDE ANY
SERVICE
6
HEREUNDER, INCLUDING LOSS OF PROFITS, LOST DATA, BUSINESS INTERRUPTIONS AND CLAIMS OF CLIENTS OR
CUSTOMERS, EXCEPT IN THE EVENT OF GROSS NEGLIGENCE, FRAUD OR WILLFUL MISCONDUCT.
(c) THE AGGREGATE LIABILITY OF SELLER UNDER THIS AGREEMENT SHALL BE LIMITED TO THE TOTAL
AMOUNTS PAID TO SELLER UNDER THIS AGREEMENT; PROVIDED,
HOWEVER, THAT THE FOREGOING
LIMITATION OF LIABILITY SHALL NOT APPLY TO SELLER’S GROSS NEGLIGENCE, FRAUD OR WILLFUL MISCONDUCT,
OR ANY BREACHES OF SECTION 7 HEREOF.
10. Notices. All notices, requests, demands, claims and other communications that are
required or may be given pursuant to this Agreement shall be delivered in accordance with Section
11.4 of the Purchase Agreement (with Buyer’s address under the Purchase Agreement constituting the
Company’s address hereunder).
11. Assignment.
(a) Neither this Agreement nor any of the rights or obligations hereunder may be assigned by
any party hereto (by contract, operation of law or otherwise) without the prior written consent of
the other party; provided, that the Company may, without the prior written consent of Seller,
assign any or all of its rights and obligations under this Agreement to one or more of its
Affiliates, but no such assignment shall relieve the Company of its obligations hereunder, and any
party may assign any or all of their respective rights or obligations to any third party who
subsequently purchases all or substantially all of the equity or assets of such party.
Notwithstanding anything else herein to the contrary, it is expressly agreed that the express
assumption by the receiving, acquiring, leasing, surviving or successor Person(s) (on a joint and
several basis with the relevant party hereto) of all of the obligations of any party shall be a
condition precedent to the transfer, sale, lease, assignment or other disposition of all or a
substantial portion of the business, operations or assets (including on a consolidated basis with
its Subsidiaries) of such party, by way of asset sale, equity sale, merger, consolidation,
liquidation, dissolution, recapitalization, operation of law or otherwise, and that further such
assumption shall be deemed to occur automatically to the maximum extent permitted by applicable
law.
(b) Subject to the foregoing, this Agreement shall be binding upon and inure to the benefit
of the parties hereto and their respective successors and permitted assigns. Nothing in this
Agreement, express or implied, is intended to or shall confer upon any Person other than the
parties to this Agreement and their successors and permitted assigns any rights, benefits or
remedies of any nature whatsoever under, or by reason of, this Agreement. No third party is
entitled to rely on any of the agreements contained in this Agreement. Seller and the Company
assume no liability to any third party because of any reliance on the agreements of Seller and the
Company contained in this Agreement.
12.
Entire Agreement; Amendments and Waivers. This Agreement constitutes the
entire agreement among the parties hereto pertaining to the subject matter hereof and
supersedes
all prior agreements, understandings, negotiations and discussions, whether oral or written,
of the
parties hereto with respect to the subject matter hereof. This Agreement may not be amended
7
except by an instrument in writing signed on behalf of each of the parties hereto. No amendment,
supplement, modification or waiver of this Agreement shall be binding unless executed in writing by
each party hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall
constitute a waiver of any other provision hereof (whether or not similar), nor shall such waiver
constitute a continuing waiver unless otherwise expressly provided.
13. GOVERNING LAW. THIS AGREEMENT, AND ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION
(I) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR (II) IN ANY WAY CONNECTED WITH OR RELATED OR
INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT OR ANY OF THE
TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND
WHETHER IN CONTRACT, TORT, EQUITY OR OTHERWISE, SHALL BE CONSTRUED, INTERPRETED AND THE RIGHTS OF
THE PARTIES DETERMINED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK (WITHOUT REFERENCE TO
THE CHOICE OF LAW PROVISIONS THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAWS
OF THE STATE OF NEW YORK).
14.
Service of Process; Consent to Jurisdiction; WAIVER OF JURY TRIAL.
(a) Each party hereto irrevocably consents to the service of any process, pleading, notices
or other papers by the mailing of copies thereof by registered, certified or first class mail,
postage prepaid, to such party at such party’s address set forth in the Purchase Agreement (with
Buyer’s address under the Purchase Agreement constituting the Company’s address hereunder), or by
any other method provided or permitted under New York law.
(b) Any claim, demand, action or cause of action (i) arising out of or relating to this
Agreement or (ii) in any way connected with or related or incidental to the dealings of the
parties hereto in respect of this Agreement or any of the transactions contemplated hereby, in
each case whether now existing or hereafter arising, and whether in contract, tort, equity or
otherwise, shall be instituted exclusively in the federal court for the Southern District of New
York, or, if such court does not take or have jurisdiction over such claim, in any New York state
court in the county of New York having jurisdiction over such claim, and each party hereto agrees
not to assert, by way of motion, as a defense or otherwise, in any such claim, that it is not
subject personally to the jurisdiction of any such court, that the claim is brought in an
inconvenient forum, that the venue of the claim is improper or that this Agreement or the subject
matter hereof may not be enforced in or by any such court. Each party hereto further irrevocably
submits to the jurisdiction of any such court in any such claim.
(c) EACH PARTY TO THIS AGREEMENT HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY
RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION (I) ARISING UNDER THIS
AGREEMENT OR (II) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE
PARTIES HERETO IN RESPECT OF THIS AGREEMENT OR ANY OF THE TRANSACTIONS RELATED HERETO, IN EACH
CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN
8
CONTRACT, TORT, EQUITY, OR OTHERWISE. EACH PARTY TO THIS AGREEMENT HEREBY AGREES AND CONSENTS THAT
ANY SUCH CLAM, DEMAND, ACTION, OR CAUSE OF ACTION WILL BE DECIDED BY TRIAL WITHOUT A JURY AND THAT
THE PARTIES TO THIS AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS AGREEMENT WITH ANY
COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO
TRIAL BY JURY.
15.
Severability. In the event that any one or more of the provisions contained in
this Agreement or in any other instrument referred to herein, shall, for any reason, be held to be
invalid, illegal or unenforceable in any respect, then to the maximum extent permitted by law,
such invalidity, illegality or unenforceability shall not affect any other provision of this
Agreement or any other such instrument.
16.
Force Majeure. Seller shall not be responsible for any delay or failure in
performance under this Agreement caused by flood, riot, insurrection, fire, earthquake, strike,
acts of government, communication line failure and power failure, explosion or act of God, or any
other force or cause beyond the reasonable control of Seller. In any such event, Seller’s
obligations hereunder shall be postponed for such time as its performance is suspended or delayed
on account thereof. Seller will promptly notify the Company upon learning of the occurrence of
such event of force majeure. In the event the force majeure event affects the provision of
Services by Seller hereunder, Seller shall use commercially reasonable efforts to remove such
force majeure event as soon as and to the extent reasonably possible and, in any event, will treat
the Company the same as any other internal or external service recipient of the affected services,
if any. Upon the cessation of the force majeure event, Seller will use commercially reasonable
efforts to resume its performance with the least possible delay. Notwithstanding the foregoing,
and notwithstanding anything to the contrary in this Agreement, the Company shall not be required
to pay for the affected Services during the pendency of an event of force majeure
17.
Headings; Construction. The descriptive headings of the Sections of this
Agreement are for convenience of reference only and are not intended to be a part of or to affect
or restrict the meaning or interpretation of this Agreement. Any of such terms, unless the context
otherwise requires, may be used in the singular or plural, depending upon the reference. All
references in this Agreement to Dollars or “$” shall mean U.S. Dollars. The use in this Agreement
of the term “including” means “including, without limitation.” The words “herein,” “hereof,”
“hereunder” and other words of similar import refer to this Agreement as a whole, and not to any
particular section, subsection, paragraph, subparagraph or clause contained in this Agreement.
18. Counterparts. This Agreement may be executed in one or more counterparts, each of
which shall be deemed an original, and all of which together shall constitute one and the same
instrument, binding upon the parties hereto. The execution of this Agreement by any of the parties
hereto may be evidenced by way of a facsimile transmission of such party’s signature, a photocopy
of such facsimile transmission or other electronic means, and such facsimile or other electronic
signature shall be deemed to constitute the original signature of such party hereto.
9
19. Relationship of the Parties. The parties hereto are independent contractors and
neither party is an employee, partner or joint venturer of the other. Under no circumstances shall
any of the employees of a party hereto be deemed to be employees of the other party for any
purpose. Neither party shall have the right to bind the other to any agreement with a third party
nor to represent itself as a partner or joint venturer of the other.
* * * * *
10
IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the date first
written above by their respective officers thereunto duly authorized.
INTERNATIONAL TECHNIDYNE CORPORATION |
||||
By: | ||||
Name: Xxxxxxxx Xxxxx | ||||
Title: President | ||||
THORATEC CORPORATION |
||||
By: | ||||
Name: Xxxxxxx X. Xxxxxxx | ||||
Title: President and Chief Executive Officer | ||||
Signature Page to the Transition Services Agreement
SCHEDULE I
Service | Service Cost/Comments | |
Health and Welfare Benefits
|
Thoratec to provide coverage for Company employees working in the United States under the following plans: (i) Thoratec Corporation BC Power Care Advocate PPO; (ii) Thoratec Corporation BC Incentive PPO; (iii) Thoratec Corporation Turfts Associated Health Maintenance Organization, Inc.; (iv) Thoratec Corporation VSP Vision Benefits Plan; (v) Thoratec Corporation Dental DHMO Benefits Plan; (vi) Thoratec Corporation Dental PPO Benefits Plan and (vii) Thoratec Corporation Xxxxxx Permanente. The Company (or an Affiliate thereof) to pay for such coverage at cost in accordance with Section 3(b)(i) of the Agreement. | |
Life Insurance Benefits
|
Thoratec to provide coverage to employees under the following programs: (i) Sun Life Basic Life and AD&D Benefits for Employees Insurance Policy, (ii) Sun Life Option Employee Life Insurance, and (ii) Sun Life Optional Dependent Life Insurance Benefit. The Company (or an Affiliate thereof) to pay for such coverage at cost in accordance with Section 3 of the Agreement. | |
Payroll Services
|
Thoratec shall, or cause its applicable subsidiaries to, continue to provide payroll services for payment of domestic and international employees of the Company, with the Company to pay for such coverage at cost. | |
Treasury Services
|
Thoratec to maintain deposit accounts for receipt of payments to the Company from customers and other third parties. Thoratec shall provide tracking services for incoming domestic and international wires. All cash held on account of the Company from and after the Closing shall be disbursed to the Company on a weekly basis; provided, that all cash held on account of the Company in the Bank One Lockbox Account (Account Number 0000000) shall be disbursed to the Company on a daily basis until the Automated Clearing House transfer to Seller has been disabled. Any and all accounts receivable or other third party payments received by Thoratec that are for the account of the Company shall be deemed to be held by Thoratec in trust for the Company, and when delivered to the Company shall be delivered without set-off or reduction of any kind. Following the expiration of the Term for such Treasury Services, Thoratec shall use commercially reasonable efforts to disburse to the Company any and all accounts receivable or other third party payments received by Thoratec that are for the account of the Company. The Company shall pay for such services at cost. |
Service | Service Cost/Comments | |
Telephony
|
Thoratec to continue to support and operate telephony systems until separation is complete (target: 90 days after Closing). Thoratec will be responsible for transfer of licenses, contracts and service agreements to the Company (of its Affiliate). The Company (or its Affiliate) will not be charged costs related to the transfer. Thoratec will be responsible for funding costs up until Closing Date; after Closing (but for max 90 days), Thoratec to xxxx the Company monthly equivalent to normal run rates in accordance with Section 3 of the Agreement. Please see IT Separation Plan set forth in Annex A for detailed input. | |
Networking services and domain services
|
Network connection to central services at Thoratec (telephony, domain services etc.) must be retained until separation is completed (target: 90 days after Closing). Thoratec will be responsible for funding WAN service provider costs up until Closing Date; after Closing (but for max 90 days) Thoratec to xxxx the Company monthly equivalent to normal run rates in accordance with Section 3 of the Agreement. Please see IT Separation Plan set forth in Annex A for detailed input. | |
Licenses, contracts and detailed IT
separation plan
|
Thoratec to continue to provide access to the Company’s data in Halogen and Taleo. Thoratec to remain owner of all relevant (in-use) software at the Company and relevant service contracts until transfer to the Company (or its Affiliate) is complete and approved by suppliers/vendors (target to complete transfer: 90 days after Closing). The Company (or its Affiliate) will not be charged costs related to the transfer. Thoratec will be responsible for funding service provider costs up until Closing Date; after Closing (but for max 90 days), Thoratec to xxxx the Company monthly equivalent to normal run rates in accordance with Section 3 of the Agreement. | |
Benefits for EU Employees
|
Thoratec to provide non-statutory benefits for all EU employees during the Term under the following plans: (i) Thoratec Europe Ltd. AXA PPP Healthcare, (ii) Thoratec Europe Ltd. Denplan Essential, (iii) Thoratec Europe Ltd. BUPA Travel, (iv) Thoratec Europe Ltd. BUPA Group Income Protection, (v) Thoratec Europe Ltd. BUPA Group Life Assurance and (vi) Thoratec Europe Ltd. Aviva Pension. The Company (or its Affiliate) to pay for such coverage at cost in accordance with Section 3(b)(i) of the Agreement. | |
Audit Support
|
Thoratec shall furnish or cause to be furnished, upon written request, information and assistance of employees of Thoratec relating to the pre-Closing operation of the Company as is reasonably necessary in order for the Company to prepare audited financial statements for the 2010 fiscal year of the Company, or to satisfy any other legitimate legal obligation or financial reporting obligation of the Company relating to the pre-Closing operation of the business of the Company, with the Company to pay for such coverage at a cost consistent with the hourly rates of the employees performing such services (or, if such employees are salaried employees, at a reasonable approximation of such employee’s per hour salary) and the Company shall reimburse Seller for all out-of-pocket expenses incurred by Seller in providing such services. |
ANNEX A
(See attached)